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“It’s far more important to know what person the disease has  
than what disease the person has.” 
Hippocrates 
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Chapter 1 
 
Zusammenfassung 
 
 
 Eine der größten Herausforderungen, die an die Entwicklung und Implementierung 
analytischer Methoden gestellt wird, ist der sensitive und spezifische Nachweis der gesuchten 
Substanzen (z.B. Medikamenten) sowie deren Quantifizierung in hochkomplexen 
Probenmatrizes. Einerseits, werden klinische Proben, wie Blut oder Urin, routinemäßig 
analysiert, um Diagnosen stellen oder den Behandlungsfortschritt erfassen zu können. 
Andererseits, wächst das Interesse an der kontinuierlichen Überwachung pharmazeutisch aktiver 
Substanzen bei der Aufbereitung von Ab- und Oberflächenwässern, vor allem um der 
Problematik der antibakteriellen Resistenz in unserem Ökosystem entgegenzutreten. In der 
Routineanalytik stellen chromatographische Verfahren, gekoppelt mit unterschiedlichen 
Detektionstechniken, den derzeitigen Goldstandard dar. Insbesondere in Kombination mit der 
Massenspektrometrie als Nachweisverfahren, wird eine hohe Sensitivität und Spezifität erreicht. 
Vor der eigentlichen Analyse sind für gewöhnlich jedoch technisch anspruchsvolle und 
arbeitsintensive Probenaufbereitungsverfahren zur Reduzierung störender Matrixeffekte 
durchzuführen. Weiterhin, erlaubt die dafür benötigte technische Instrumentierung/Ausstattung 
keine einfache Analyse auf Knopfdruck, ist in ihrer Anschaffung sowie dem Betrieb mit hohen 
Kosten verbunden sowie aufgrund ihrer Größe nicht für Vor-Ort-Anwendungen geeignet. 
Weiterhin bestehen keine einheitlichen Standards für  Analyseprotokolle, wodurch jeweils eine 
individuelle Kalibrierung in Abhängigkeit der gesuchten Substanz notwendig ist. Eine weitere 
Methode, die bereits fest in der klinischen Praxis verankert ist, stellen Immunoassays dar, von 
denen derzeitig mehr als 25 verschiedene „Kits“ kommerziell verfügbar sind. Ihr hoher Grad an 
Automatisierung ermöglicht eine einfache Implementierung dieser Technik in klinischen 
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Laboratorien und die Resultate verschiedener Zentren weisen eine hohe Vergleichbarkeit auf. 
Allerdings ist das Auftreten unerwünschter Kreuzreaktionen, auch 60 Jahre nach der ersten 
Demonstration, nach wie vor ein großes Problem. In diesem Zusammenhang erweist sich die 
Multiplexdetektion ebenfalls als große Herausforderung. 
 Zu den neu entwickelten analytischen Techniken gehörend, weist die 
oberflächenverstärkte Raman-Spektroskopie (SERS, engl. surface enhanced Raman 
spectroscopy) großes Potential als Alternativmethode für die Detektion klinisch- sowie 
umweltsrelevanter Moleküle in komplexen Probenmatrizes auf. Die Methode beruht auf den 
molekularen Informationen, erhalten durch inelastische Lichtstreuung an sich in der Probe 
befindlicher Moleküle, vereint mit der Signalverstärkung (bis zu 10
11
) durch die plasmonischen 
Eigenschaften von Nanopartikeln aus Münzmetallen. Damit erfüllt SERS die wichtigen 
Voraussetzungen, Spezifität und Sensitivität, an analytische Techniken. Die größten 
Hindernisse, welche den Einsatz in der Standardanalytik bisher weitgehend verhindert haben, 
sind die geringe Reproduzierbarkeit der Resultate sowie die mangelnde Automatisierung der 
Methode. Eine oft vorgeschlagene Methode zur Erhöhung der Zuverlässigkeit besteht in der 
Verwendung hochgeordneter, planarer Strukturen als SERS-Substrat. Diese sind jedoch mit 
hohen Herstellungskosten verbunden. Des Weiteren stellt die Frage nach der optimalen 
Auftragung des Probenmaterials eine Herausforderung dar. Bisher konnte kein automatisiertes 
Messverfahren mit planaren Substraten realisiert werden. Ein alternativer Ansatz, welcher 
reproduzierbare und automatisierte Messbedingungen unter Einsatz kostengünstiger SERS-
Substrate gewährleistet, ist die tropfenbasierte, mikrofluidische Lab-on-a-Chip SERS- (LoC-
SERS) Technik. Diese Plattform ermöglicht eine direkte, chipbasierte Untersuchung der Proben 
gestützt auf die präzise Manipulation von Nanopartikel- und Probelösung über ein 
computergesteuertes Pumpensystem. 
 In letzter Zeit häufen sich Studien, die auf die Wichtigkeit und Notwendigkeit einer 
personalisierten Medizin hinweisen. Methotrexat gehört zu den wirksamsten 
Chemotherapeutika, verursacht jedoch häufig toxische Ereignisse aufgrund einer Überdosierung. 
Für Studien zur Auffindung optimal wirksamer Dosen für Antibiotika, wie Levofloxacin, wird 
oft auf gesunde Freiwillige zurückgegriffen. Die mittels dieser Studien gefundenen Werte 
können jedoch häufig nicht auf Patienten, die sich auf der Intensivstation befinden, übertragen 
werden. Darüber hinaus ist eine kontinuierliche Anpassung der Behandlungsvorschriften 
notwendig, um dem Auftreten multiresistenter Erreger sowie der Entwicklung neuer, 
wirksamerer antibakterieller Medikamente zu begegnen. Nitroxilin ist eines von mehreren 
Antibiotika, welche erst kürzlich in diesem Zusammenhang von dem Nationalen Antibiotika-
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Sensitivitätstest-Komitee in Bonn (NAK) neu bewertet wurden. Ein weiterer wichtiger Aspekt 
ist die Tatsache, dass die Entwicklung multiresistenter Keime nicht nur räumlich beschränkt, 
beispielsweise in medizinischen Einrichtungen, sondern im gesamten Ökosystem abläuft. Der 
übermäßige Einsatz von Antibiotika in der Humanmedizin und der Massentierhaltung ist ein 
ernsthaftes Problem unserer Zeit. Dadurch gelangen aktive Metaboliten als auch unveränderte 
Substanzen im Fall solcher Medikamente, die nur geringfügig verstoffwechselt werden, ins 
Ökosystem. Letzteres ist beispielsweise bei dem Antibiotikum Ciprofloxacin der Fall. 
 Das Ziel der vorliegenden Dissertation ist die Beurteilung des Potentials sowie der 
Limitierungen der LoC-SERS-Technik für den Nachweis und die Quantifizierung 
unterschiedlicher Medikamente in komplexen Probenmatrizes. Als SERS-Substrate kommen 
dabei einfach herstellbare Silbernanopartikel in einer kolloidalen, wässrigen Lösung zum 
Einsatz. Die Probenaufreinigung beschränkt sich auf Filtration und Verdünnung mit Wasser. Die 
verwendeten Urinproben stammen von gesunden Freiwilligen sowie Patienten mit 
Harnwegserkrankungen. Weiterhin werden Flusswasserproben in der vorliegenden Arbeit 
untersucht. Die analytische Leistungsfähigkeit, gemessen an Parametern wie dem 
Detektionslimit (LOD, engl. limit of detection), dem linearen und dynamischen Bereich und der 
Wiederholbarkeit von Messungen, wird für die Medikamente Methotrexat, Levofloxacin, 
Nitroxolin und Ciprofloxacin getestet. Darüber hinaus, wird durch die Verwendbarkeit eines 
transportablen Messgerätes anstelle eines fest installierten Aufbaus das Potential der LoC-SERS-
Plattform für Vor-Ort-Anwendungen demonstriert. 
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1.1 Summary 
 
 Detection and quantification of drugs in complex matrices challenged each analytical 
method at its moment of development and implementation. On one side, clinical samples, i.e. 
blood and urine, are routinely analyzed for diagnosis and treatment follow-up purposes. On the 
other side, monitoring the successful removal of pharmaceutically active compounds in waste 
and surface water is of high interest to overcome the occurrence of antibacterial resistance in the 
ecosystem. Before the actual analysis, sophisticated and labor-intensive sample clean-up 
procedures are commonly applied in the routine analysis to reduce matrix effects. Regardless of 
the application field, chromatography coupled with various detection methods is the gold 
standard. Sensitivity and specificity, two key requirements of analytical instrumentation, 
represent the strength of chromatography platforms, especially for the ones using mass 
spectrometry as a detection technique. However, they are not “turn-key” instruments, they are 
associated with high initial and maintenance costs, and thus, they are not accessible for small 
medical centers, they lack standardization and the big footprint inhibits their on-site application. 
In clinical chemistry practice, immunoassays are also well established. Currently, more than 25 
commercial immunoassays are available on the market. Because of their automation, they are 
easily integrated into clinical laboratories and results obtained by different clinical centers are 
comparable. Nevertheless, after more than 60 years since their first use, cross-reactivity is still a 
drawback, while multiplex detection is a big challenge. 
 Among the newly developed analytical techniques, surface enhanced Raman 
spectroscopy (SERS) has high potential to be considered as an alternative analytical technique 
for the detection of clinically and environmentally relevant molecules in complex matrices. The 
method takes advantage of the molecular information offered by the inelastically scattered light 
by molecules in the sample and the signal enhancement (up to 10
11
) caused by the plasmonic 
properties of coinage metallic nanoparticles. Consequently, SERS fulfills the key requirements, 
specificity and sensitivity, of analytical instrumentations. The biggest barrier for its application 
is the low reproducibility of measurements and automation. One of the suggested solutions to 
increase reliability is to use highly ordered planar structures as SERS active substrates. 
Nevertheless, these imply high production costs, challenges regarding the correct sample 
deposition appear and the automation is not achieved. An alternative solution that requires low-
cost SERS substrates and offers reproducible and automated measurement conditions at the 
same time is represented by the droplet based lab-on-a-chip SERS (LoC-SERS) technique. This 
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platform offers the advantage of highly precise controlled manipulation of nanoparticle and 
sample solution via computer controlled systems and a direct, on chip detection.  
  Recently, many studies reported on the importance and necessity of personalized 
medicine. Methotrexate is one of the most potent anticancer drugs, but at the same time, it is also 
the one having the most reported toxic events. Dose finding studies for antibiotics, i.e. 
levofloxacin, often recruit healthy volunteers. Fixed dose regimens derived from these clinical 
trials fail in the critically ill intensive care unit patients. Moreover, a continuous change of 
treatment guidelines is needed because of the occurrence of antibacterial resistances or because 
of the discovery of new, more potent antibiotics. Nitroxoline is one of the antimicrobial agents 
recently reevaluated by the German Antimicrobial Susceptibility Testing Committee. One other 
site for the development of antibacterial resistances, beside medical centers, is the ecosystem. 
Overuse of antimicrobial agents weakly metabolized, i.e. ciprofloxacin, or with active 
metabolites, in live-stock raising and medical treatments present a major issue of the human 
society.   
 Consequently, the aim of the present thesis was to assess the potential and limitations of 
the LoC-SERS technique to detect and quantify drugs in various complex matrices. As SERS 
active substrates, easy-to-prepare silver nanoparticles in a colloidal solution were employed and 
as sample clean-up procedure filtration and dilution with water was carried out. Urine samples 
originating from healthy volunteers and patients with urinary tract infection, as well as river 
water sample were included in the present study. Analytical performances, such as lower limit of 
detection (LOD), linear and dynamic range and measurement reproducibility, were tested for 
methotrexate, levofloxacin, nitroxoline and ciprofloxacin. Furthermore, the potential of the LoC-
SERS platform for on-site applications is also demonstrated by replacing the bench-top Raman 
microscope by a portable one.  
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1.2 Motivation 
 
 
 Health care and environment protection are two of the main concerns of nowadays 
society. Although the two aspects seem to have no interconnection, the emerging antibacterial 
resistances are the result of irresponsible use of antimicrobial agents in medical treatments 
followed by the unsuccessful removal of pharmaceutically active compounds from the 
ecosystem. The World Economic Forum Global Risks reports have classified antibacterial 
resistance as one of the greatest threats to human health and associated it with high financial 
costs [1, 2]. An additional factor that puts a high burden on health care costs is the 
ineffectiveness of fix dose medical treatments caused by the individuality of each patient, the 
patient compliance, bioavailability of the drug, rate of drug metabolism as well as the protein 
binding capability of the drug [3]. Therefore, in order to increase the efficiency of medical 
treatments and lower the associated financial costs personalized medicine is highly encouraged. 
 In pharmacotherapy, two different parameters are used to assess the required dose of a 
drug to achieve a given medical outcome. Pharmacokinetics (PK) describes the drug 
concentration in body fluids over time for a specific drug dose, while pharmacodynamics (PD) 
gives information about the effect of a certain drug concentration [4]. PK/PD modelling links the 
administered dose with the concentration in body fluids and the therapeutic response and 
predicts the effect over time of a certain drug dose. Nowadays, different physiological indices of 
pharmacological response are routinely measured (lipid concentrations, blood glucose, blood 
pressure) in order to determine the PK/PD characteristics of drugs. However, there are many 
drugs with insufficiently sensitive or no direct indicator of their therapeutic response. In these 
cases, therapeutic drug monitoring (TDM) is applied which was defined as “the measurement 
made in the laboratory of a parameter that, with appropriate interpretation, will directly 
influence prescribing procedures. Commonly, the measurement is in a biological matrix of a 
prescribed xenobiotic, but it may also be of an endogenous compound prescribed as a 
replacement therapy in an individual who is physiologically or pathologically deficient in that 
compound” [5].  
 The determination of drug levels in biological fluids is performed by methods based on 
chromatographic separation or immunological assays [6-23]. On one hand, the first approach 
offers great specificity and sensitivity for, theoretically, all existing drugs, but it is mainly 
available in reference clinical laboratories and academic centers because of the required high 
initial financial investment. On the other hand, immunological assays (or immunoassays) are 
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easy to integrate in a clinical setting, but they are available for only a limited number of drugs 
due to the need of specific antibodies.  
 Among the emerging techniques, methods based on vibrational spectroscopy yield the 
required specificity for drug detection and are considered as potential alternative analytical 
instrumentation to chromatography platforms [11, 24-32]. Especially Raman spectroscopy can 
be easily performed in biological fluids due to the low scattering cross section of the water 
molecules. Hence, no or very reduced sample clean-up procedure is needed prior to the 
measurements. The method is based on the inherently weak inelastic light scattering of photons 
by the sample and, thus, the detection of trace amount of molecules is inhibited. Various signal 
enhancement strategies have been applied throughout the years among which SERS was widely 
recognized for its exquisite sensitivity at single molecule level [33-35]. The technique gains its 
high sensitivity from the enhanced local electromagnetic field of plasmonic nanostructures 
excited with the appropriate electromagnetic radiation. The development of a high diversity of 
SERS active substrates [36-42] is driven by the need of a stable, easy-to-synthesize and cost-
effective nanostructure which offers homogenous signal enhancements (for analytical 
applications) or strong local electromagnetic fields (for single molecule applications). Colloidal 
silver and gold solutions obtained by chemical reduction [40, 42-44] are the most commonly 
used plasmonic substrates, regardless of the aimed application. The drawbacks associated with 
these nanoparticles, i.e. low reproducibility of the measurements because of the aggregation time 
dependent SERS signal and low automation [45], can be easily overcome by applying them in 
microfluidic setups [46-55]. By employing the droplet based LoC-SERS technique the 
manipulation of the nanoparticles and sample solutions is controlled with high precision via 
computer controlled systems and the detection is carried out on-line [29, 50, 55-58]. 
Furthermore, LoC-SERS measurements can be easily carried out with portable Raman setups 
significantly reducing the overall costs and facilitating its on-site application.  
 The aim of the present study was to assess the potential and limitation of the LoC-SERS 
technology for the detection and quantification of drugs in both clinical and environmental 
samples. For this, the antifolate drug methotrexate (MTX) and three antibiotic agents, 
levofloxacin, nitroxoline (NTX) and ciprofloxacin were investigated. 
 Low-dose (LD) (5-25 mg/week) MTX is first-line therapy for the treatment of 
rheumatoid arthritis, while the drug is administered in high-dose (HD) (5000 mg/week) for 
cancer treatment [6, 59-61]. The exact mechanism of action of the drug in the LD schemes is not 
completely understood. Four different routes have been suggested in literature: MTX might 
inhibit (1) the proliferation of cells responsible for synovial inflammation or (2) the synthesis of 
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potentially toxic compounds that accumulate in chronically inflamed tissues; (3) it might reduce 
intracellular glutathione levels or (4) adenosine might mediate its anti-inflammatory effects. In 
HD treatments, the drugs block the action of folic acid, and thus it inhibits the dihydrofolate 
reductase process in cells [62]. However, this is not restricted only to cancerous cells and 
concomitant administration of leucovorin, a form of folic acid, is practiced [61]. To reduce the 
side effects of MTX TDM is performed during HD treatment schemes [12, 63]. In most medical 
guidelines a plasma MTX concentration ≤ 0.2 µM allows the clinician to stop leucovorin 
administration [63], at 42 h after the start of MTX infusion target concentrations are  ≤1 µM, 
while high risk toxic effect are associated with concentrations ≥ 10 µM [64, 65]. 
 Levofloxacin is a second generation fluoroquinolone antibiotic widely used against 
infections caused by both Gram-negative and Gram-positive bacteria [66, 67]. The fluorine atom 
attached to the quinolone backbone provides increased potency against organisms, while the 
piperazine moiety is responsible for pseudonomal activity [68]. Its PK/PD parameters, as in the 
case of most antimicrobial agents, was assessed during clinical trials carried out with healthy 
volunteers instead of patient volunteers [66, 69, 70]. However, multiple studies have been 
reported demonstrating that fixed dose regimens derived from such studies fail in critically ill 
intensive care unit patient [71]. Furthermore, even though levofloxacin is generally well 
tolerated, various studies report about its adverse effects, such as: tenosynovitis [72], crystal 
nephropathy [73], hepatotoxicity [74], PK interaction [75, 76], Achilles rupture and [77] 
metabolic coma [78]. Additionally, in the case of obese patients altered clearance rates of the 
antibiotic have been observed, as compared with the case of normal patients with normal weight 
[79]. Levofloxacin undergoes limited metabolism in the human body. More than 85 % of the 
administered dose is eliminated in urine unchanged [66]. Thus, its clearance rate can be easily 
monitored by determining its urinary concentration. Based on PK studies carried out with 
healthy volunteers, the expected drug concentration in urine after 4 h from the administration of 
a single oral dose of 500 mg are 1.38 mM ± 0.68 mM (498 ± 247 μg/ml) with the minimum 
measured concentration of 0.45 mM (162.6 µg/ml) [69, 70]. 
 Fluoroquinolones have been widely used to treat urinary tract infections, especially 
cystitis and acute pyelonephritis [80]. However, medical guidelines indicate the co-
administration of a second, long-acting antimicrobial agent if the regional resistance rate is 
higher than 10% [80]. Generally, the emerging antibacterial resistances require the change of 
treatment guidelines in order to provide an effective treatment. As the number of the newly 
developed antimicrobial agents is very limited, the attention of the medical community is often 
directed toward older antibiotics. NTX has been recently reevaluated by the by the German 
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Antimicrobial Susceptibility Testing Committee [81]. The drug acts by chelating the divalent 
cations required for bacterial RNA polymerase [82]. The minimum inhibitory concentration 
(MIC), defined as the lowest concentration of an antimicrobial that will inhibit the visible 
growth of a microorganism after overnight incubation, in the case of NTX is 2-4 mg/l (10.5-21.0 
μM) for various E. coli strains, 4 mg/l (21.0 μM) for K. pneumoniae and 8 mg/l (42.1 μM) for 
Proteus mirabilis and S. saprophyticus [81, 83]. These values are in the susceptible range, while 
MICs≥16 mg/l (84.2 μM) are regarded as resistant. The information available in the literature 
concerning analytical methods for NTX detection is very scarce. Thus, there is a high need for 
the development of a new, easy to access instrumentation dedicated to determine NTX levels in 
order to avoid the occurrence of resistances. 
 Even though personalized medicine is highly desired and recommended, it encounters 
big obstacles due to the absence of accessible analytical instrumentation and due to the way 
medical practice is carried out. Generally, drug indigestion is followed by its absorption, 
distribution, metabolism and elimination. Therefore, pharmaceutically active compounds will be 
present in wastewaters. Monitoring the successful removal of antibiotics from the ecosystem is 
of high importance. Drinking water treatment plants play an important role in the removal of the 
unwanted compounds. Nevertheless, because of the strong fluctuations throughout the year, the 
effectiveness of the cleaning process has to be continuously monitored. Ciprofloxacin, also a 
fluoroquinolone antibiotic, is excreted in urine, with the parental drug representing more than 
50 %. This and the fact that for some medical treatments the drug dose is 1000 mg [66], its 
concentration in environmental samples might exceed the MIC values (0.024 µM for E. Coli to 
12 µM for S. aureus). Therefore, in order to avoid the creation of drug-resistant bacteria strains, 
beside responsible medical practice, also the prevention of the presence of antibiotics in the 
ecosystem is of high interest. 
 In the following section of the thesis, the current state of research will be summarized. 
Details concerning the basic principles of the reference analytical methods will be described 
together with their application in the detection of the four drugs presented above. This will be 
followed by the introduction of the LoC-SERS technique as an alternative detection method to 
the available reference methods. In the last section of the thesis, the results published in five 
different manuscripts will be summarized with highlighting the potential and limitations of the 
applied analytical method.  
Analytical Methods for Drug Detection – current state of research 
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1.3 Analytical Methods for Drug Detection – current state of research 
 
1.3.1 Reference analytical methods 
 
Clinical samples  
 
At the beginning of the 20
th
 century neither the PK or PD concept existed. The first 
mathematical model describing drug elimination rates was published in 1924 by Widmark and 
Tandberg [84, 85]. 40 years later drug level determinations were established in the clinical 
environment. The biggest barrier against advancement was the absence of appropriate analytical 
methods. Although gas chromatography (GC) was already used to monitor antiepileptic drugs at 
the beginning of the 1950s, the antibody-based immunoassays won the competition twenty years 
later due to their accuracy and easy integration into clinical laboratory. Nowadays, both 
chromatography and immunoassay methods are in use due to the different needs and capabilities 
of individual laboratories [86]. In the following, a brief description of these techniques will be 
presented together with their pros and cons and their application for detecting MTX, 
levofloxacin and NTX in body fluids.  
 
Immunoassays 
 
The discovery of the immunization process by Berson and Yalow [87] led to the first 
insulin immunoassay. Currently, there are over 25 immunoassays commercially available and 
routinely used in drug monitoring [88]. Among the homogeneous platforms, fluorescence 
polarization immunoassay (FPIA), enzyme multiplied immunoassay technique (EMIT®) and the 
cloned enzyme donor immunoassay (CEDIA®) are leading the market. Heterogeneous assays 
are ADVIA Chemistry, Centaur®, ACCESS®, Elecsys® and AxSym®. 
The working principle of the platforms is governed by the antigen-antibody binding 
reaction. The technique gains its high specificity and sensitivity from three important properties 
of the antibodies: (1) the ability to bind to both natural and synthetic molecules, (2) specific 
binding and (3) the binding strength [89].  
Two different designs are available: immunometric and competition assays [88]. The 
first one is also referred to as “sandwich” assay because it uses two different specific antibodies 
that form a sandwich around the target of interest. These platforms (i.e. the enzyme-linked 
Analytical Methods for Drug Detection – current state of research 
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immunosorbent assay (ELISA)) are mainly applied for the detection of molecules with large 
molecular weight, such as proteins or peptides. For the detection of small weight molecules, i.e. 
drugs, the competition design is preferred. Here, the target molecule competes with a fixed 
amount of tracer (labeled molecule) for a limited number of antibodies [9]. The affinity for the 
antibody of the molecule is higher as compared with the affinity of the tracer. Therefore, when 
the target molecule is present in the sample, fewer tracers will bind to the antibody as compared 
with the situation when the sample contains no such molecule. The activity (i.e. radiation, 
fluorescence or enzymatic activity) of the tracer is the one measured in order to determine the 
concentration of the molecule in the sample. If the signal comes from the bound tracers the 
concentration of the molecule will be indirectly proportional to the signal, whereas when the free 
fraction is measured, the concentration is directly proportional to the signal. There are two 
variations of the competitive assays: the heterogeneous and the homogeneous one. In the first 
case, the unbound tracers are separated by physical or chemical techniques from the antibody-
antigen complex prior to measurements. In the second case, the tracer generates a signal only 
when it is bound to the antibody, therefore, no separation is needed.  
MTX is one of the most potent anticancer drug, but at the same time, it is also the one 
having the most reported toxic events. Thus, the number of developed immunoassays for its 
detection is very high. Siemens commercializes the ARK™ Methotrexate Assay [90, 91], while 
Abbott Diagnostics offers the TDx/TDxFLx Methotrexate II assay [92] and the Architect 
Methotrexate chemiluminescent assay [93]. A forth assay is available at a Japanese company, 
the Nanopia eTDM Methotrexate from SEKISUI MEDICAL CO. [12]. Generally, the analytical 
range of these platforms is between 0.01 µM and 1.2 µM. For samples having MTX 
concentration higher than the upper limit of quantification (LOQ) dilution must be carried out. 
This presents two main disadvantages: (1) longer analysis time due to repetition and (2) errors 
induced by a subsequent step. Furthermore, each assay has its own specific reagents. Once the 
company is withdrawing the reagents from the market, the detection platforms have to be also 
changed [63] if no new generation reagents are provided. This will lead to unexpected costs for 
the clinical laboratories. Additionally, it was reported, the change of the reagents, can lead to 
overestimation of the MTX concentrations [63]. No commercial immunoassay is available for 
levofloxacin or NTX detection in biological fluids. However, recently a study has been 
published by Shanin et al. [94] concerning the detection of levofloxacin by FPIA in human 
urine. Garenoxacin tagged by 4'-aminomethylfluorescein was used as tracer yielding a detection 
limit of 1 ng/ml and a linear dynamic range between 2.5 to 50 ng/ml. Because levofloxacin 
concentrations in human urine are high (~498 ± 247 μg/ml), the urine samples were diluted 40 
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times prior to the measurements. Furthermore, cross-reactivity was observed for multiple drugs 
closely related to levofloxacin. 
Overall, immunoassays offer numerous advantages and thus, they are often encountered 
in the clinical chemistry laboratories [86]. They are easily integrated due to their simplicity. The 
excellent automation removes the potential source of human errors. Immunoassays purchased 
from the same manufacturer share the same method leading to comparable results in between 
laboratories. But, after more than 60 years of history, immunoassays are still presenting cross-
reactions with metabolites and other substances, while multiplexing is still a big challenge. The 
development of new assays is time-consuming (up to one year) and most often the consumer has 
to rely on immunoassays developed by companies. Furthermore, in many cases, a dilution of the 
samples is needed in order to decrease the concentration of the target molecule in the sample. 
This can lead to errors as well as to increased reagent volumes needed for analysis.  
 
 
Chromatography methods 
 
Although immunoassays are leading the market in the field of clinical chemistry, 
chromatography techniques are still considered to be the reference methods for drug detection 
and monitoring. Their main advantages over immunoassays are the exquisite selectivity, the 
ability to develop new assays in a more rapid time frame, as well as the possibility to detect 
several compounds in a single run [86].  
Chromatography methods can be divided into three main classes: GC, liquid 
chromatography (LC) and supercritical fluid chromatography (SFC). For drug detection both GC 
and LC techniques are commonly applied, whereas SCF is mainly used in industry for the 
separation of chiral molecules [95]. Regardless of the chosen chromatography method, the 
sample analysis process has three steps. The first one consists in a sample pre-treatment 
procedure. This is followed by the separation of individual compounds in distinct elution bands. 
Finally, the identification is carried out with various detectors.   
The sample preparation plays a major role in the analytical procedure as it has a great 
influence on all subsequent analytical steps. The aim of all sample clean-up procedures is to 
extract the target analyte from the biological samples with high recovery rates and to minimize 
the matrix effects [96]. The most commonly encountered sample treatment procedures include 
liquid-liquid extraction (LLE), protein precipitation (PP) and solid-phase extraction (SPE). 
Decades ago these protocols were developed in-house, making it impossible to compare results 
in between laboratories. Additionally, it was the most labor-intensive and error-prone process in 
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the overall bioanalytical methodology [96]. Currently, for many of these procedures, commercial 
kits are available. For example, the development of membrane-based PP filter plates [97, 98] 
allowed the automation of the PP step and the reduction of the sample preparation time from 4-
5 h to 1-1.5 h. Furthermore, a major advancement was brought by the introduction of the on-line 
solid phase extraction (OLSPE) platforms. Two types of OLSPEs are commercialized: the 
restricted access material (RAM) column [99, 100] and the turbulent flow chromatography 
(TFC) column [101]. Both columns separate small molecules, such as drugs, from large 
molecular species (proteins) in a biological matrix. They function as pre-column units and are 
combined with the analytical column via a column switching procedure. 
After an effective sample clean-up procedure, the chromatographic separation is carried 
out. The working principle of all systems relies on a mobile phase having the role to transport 
the analytes through a column that contains the stationary phase [95]. The molecules in the 
sample interact with the stationary phase. Depending on the chemical structure of each analyte, 
the interaction strength is varying. Thus, the separation is achieved based on the retention time in 
the separation column.  
Although GC has a great analytical performance, it is limited to the detection of volatile 
non-polar compounds [88, 95]. LC, on the other hand, has no such limitations, both polar and 
non-polar molecules can be successfully separated. After more than one century from its 
discovery by Michael Tswett, there have been numberless variations of LC techniques reported 
and summarized in review articles [14, 22, 102-106]. Column based LC method is the most 
commonly used one. Separation can be performed in the “normal” configuration, where the 
stationary phase is polar and the mobile phase is nonpolar; or in the “reverse phase” 
configuration, where the stationary phase is nonpolar and the mobile phase is polar. The last 
developments in the field aimed toward fast LC [106]. For this, new column sorbents were 
prepared [107, 108], separation was performed at high temperatures [109] or ultra-high 
performance liquid chromatography (UHPLC) [18, 19] was introduced. Another popular 
analytical method for drug analysis application is the hydrophilic interaction liquid 
chromatography (HILIC) [23, 110, 111]. 
Chromatographic separation only does not provide information about the identity of the 
eluted molecules. For identification, different detectors can be used, such as UV-Vis absorption, 
fluorescence detection (FLD), Fourier transformed infrared spectroscopy or mass spectrometry 
(MS) [95]. UV-Vis detectors are commonly available on the high-performance liquid 
chromatography (HPLC) platforms since most of the organic molecules have a chromophore 
capable of absorbing either UV or visible light. Fluorescence detectors can be used for 
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molecules capable of fluorescing, whereas MS is a universal detector. Initially, HPLC-MS 
techniques were mainly used only in research facilities due to their high costs. However, because 
of their exceptional sensitivity and selectivity originating from the detection of charged particles 
based on their mass, the accessibility was increased thanks to the undertaken technological 
advances.  
Contrary to the case of immunoassays, chromatography methods are not “turnkey” 
analyzers. Protocols are in-house developed and adapted for specific requirements. This leads to 
an impressive number of publications. Molecules which cannot be detected by immunoassays 
because of the absence of an appropriate antibody can be easily quantified with LC methods. 
More than 300 publications related to the LC determination of MTX in biological fluids 
have been reported, with more than 40 studies published in the last five years. Table 1 
summarizes the analytical performances achieved in selected publications. Most of these studies 
used MS for detection. Furthermore, most often beside MTX also its metabolites were 
quantified. As biological matrix either human plasma or serum was considered. Prior to 
measurements, manual PP was carried out and only in one case SPE was applied. Information 
regarding the run-time of the chromatographic separation was not provided by all authors. The 
linear response and the LOQ values varied strongly between methods. This is one of the factors 
which inhibits result comparison in between laboratories. 
 
Table 1. Recently published studies on MTX detection. 
 
Method 
Detected 
molecules 
Sample 
Sample 
treatment 
Run-
time 
Linear range LOQ Ref. 
HPLC-UV MTX serum SPE 12 min 0.025-5 µM 0.01 µM [62] 
LC-
MS/MS 
MTX 
7-OH-MTX 
plasma on-line PP - 0.025-50 µM 0.025 µM [7] 
HPLC-UV MTX serum centrifugation - 0.058-1.39 µM 0.019 µM [112] 
HPLC-UV MTX serum PP 10 min 0.11 –22 µM 0.044 µM [113] 
TFC–LC–
MS/MS 
MTX, 
7-OH-MTX, 
DAMPA 
serum PP  0.01-1 µM 0.01 µM [114] 
LC-
MS/MS 
MTX plasma PP 5 min 110 pM–55 nM 110 pM [115] 
LC-
MS/MS 
MTX serum PP 5 min 0.01–1 µM 0.01 µM [116] 
LC-
MS/MS 
MTX plasma dilution, PP 3 min 0.005-50 μM 0.005 µM [10] 
HPLC-
FLD 
MTX, 
7-OH-MTX, 
DAMPA 
plasma PP - 0.010-20 μM 0.005 µM [117] 
  
Abbreviations: 7-OH-MTX: 7-hydroxy methotrexate, SRM: selected reaction monitor, DAMPA: 4-amino-
4-deoxy-N10-methylpteroic acid. 
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In the case of levofloxacin, nine publications are summarized in Table 2. In comparison 
with the LC assays for MTX detection, the number of concomitantly determined drugs is higher. 
Additionally, beside human plasma, other biological samples were also analyzed. As in the case 
of MTX, the most commonly encountered sample clean-up procedure was done by PP. The run-
times are considerably longer when compared with the run-times in Table 1. But this is due to 
the simultaneous detection of multiple antibiotics in the same run. Linear ranges and LOQs are 
once again method dependent. By taking into account that no commercial immunoassay is 
available for levofloxacin detection in biological fluids, LC methods found a niche and present a 
great advantage due to their multiplexing capabilities. 
 As already mentioned before, in the case of NTX the number of reported studies 
concerning its detection is very limited. In 1981 Sorel et al. [118] published the first and only 
 
Table 2. Recently published studies on levofloxacin detection. 
 
Method Detected molecules Sample 
Sample 
treatment 
Run-
time 
Linear range LOQ Ref. 
HPLC-UV 
linezolid rifampicin 
levofloxacin 
moxifloxacin 
plasma PP 28 min - 0.63 µM [119] 
HPLC-UV 
and FLD 
levofloxacin 
+ 
5 quinolones 
plasma 
ultrafiltrati
on 
- 
0.13-27 µM
i 
0.055-13 µM
ii
 
- [120] 
SPE-HPLC-
UV 
levofloxacin 
plasma,  
bone 
tissues 
SPE 12 min - 0.2 µg/g [121] 
HPLC-UV 
levofloxacin 
gatifloxacin 
moxifloxaci 
plasma 
on-line 
extraction  
- 0.34-11 µM 0.34 µM [122] 
HPLC-FLD levofloxacin plasma  - 0.14–14.4 µM 0.14 µM [123] 
HPLC-UV 
linezolid tinidazole 
levofloxacin  
+ 
5 quinolones 
plasma PP - 0.27–27 µM 0.27 µM [124] 
HPLC-UV 
levofloxacin  
+ 
4 quinolones 
plasma PP - 0.055–13 µM 0.055 µM [125] 
UHPLC–
MS/MS 
beta-lactams 
aminoglycosides 
penicillins 
cephalosporins 
carbapenems 
quinolones 
urine, 
serum 
dilution, 
PP 
<6 min - 
1.38 µM
iii 
0.27 µM
iv [126] 
HPLC-UV levofloxacin plasma PP 4.5 min 0.276–33 μM - [127] 
 
i
UV, 
ii
 FLD, 
iii
 urine, 
iv
 serum 
Abbreviations: MS/MS: tandem mass spectrometry 
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HPLC analysis of NTX in human urine and plasma. The determined limit of detection was 0.42 
µM and a linear range between 0.415 and 208 µM was obtained for the plasma samples. 
However, the method presented tailing effects due to co-elution of NTX with structurally related 
compounds present as impurities. More than twenty years later, Kang et al. [128] reported the 
detection of NTX by HPLC-UV method. Nevertheless, the molecule was detected in its pure 
form for the purpose of quality control rather than for clinical purposes.      
   
Environmental samples 
 
Chromatographic separation combined with MS is also the reference analytical method 
for the detection of pharmaceutically active chemicals in environmental samples. Before 
detection, the molecules have to be pre-concentrated via either off-line or on-line SPE 
procedures. The sampled volumes range between 500-1000 ml for the off-line SPE method, 
whereas for on-line pre-concentrations this can be reduced to 50-100 ml [129]. When tandem 
MS is employed as detection, the sample volume is reduced below 5 ml, but the equipment cost 
is considerably increased. 
 Depending on the objectives pursued, the screening methods for environmental samples 
were divided in three different categories [129]. Qualitative and semi-quantitative techniques 
aim to quickly detect the presence of one or more compounds in the sample. Quantitative 
methods provide the exact concentration of the chemical compound in the sample, whereas 
confirmatory methods certify the identity of the compound with or without quantitative 
determinations. Another classification is based on whether the detection is focused on one 
specific molecule or not [130]. In the case of the pre-target screening, the molecule is a priori 
selected and no other compounds are detected. For the post-target screening all molecules are 
detected followed by the confirmation of the identity of a post-selected molecule. Finally, the 
non-target screening, referred to as general unknown screening, detects all chemicals accessible 
to the particular analysis and focuses on unexpected or unknown substances. The pre-targeted 
screening method is currently the most commonly used technique facilitating the detection of 
multiple molecules [131-134]. 
FLD and MS/MS techniques are commonly used for ciprofloxacin detection after the 
chromatographic extraction with LC or HPLC. Table 3 summarizes eight selected publications. 
All techniques perform multiplex analysis. Besides ciprofloxacin two to nine other 
fluoroquinolones were simultaneously detected in various environmental samples. After SPE or 
filtration procedures the LOQ values range between 1.44 pM to 2.33 nM. 
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Table 3. Recently published studies on ciprofloxacin detection. 
 
Method 
Detected 
molecules 
Sample 
Sample 
treatment 
Linear range LOQ Ref. 
LC-FLD 
LC-MS/MS 
Ciprofloxacin 
9 other FQ 
sewage SPE 0.27-59 nM  
100 
pg* 
[135] 
LC-MC/MS 
Ciprofloxacin 
4 other FQ 
surface water 
 sewage 
SPME 0.3-300 nM 51 pM [136] 
LC-FLD 
LC-MS/MS 
Ciprofloxacin 
3 other FQ 
sewage SSPE - 30 pM [137] 
LC-fluorescence 
norfloxacin 
ciprofloxacin 
enrofloxacin 
surface water filtration 150-3000 nM 75 pM [138] 
HPLC-FLD 
Ciprofloxacin 
4 other FQ 
surface water 
groundwater  
sewage 
SPME 2.3–150 nM 
2.33 
nM 
[139] 
LC-MS/MS 
Ciprofloxacin 
5 other FQ 
surface water MMIP 60 pM-6 nM 16 pM [140] 
LC-FLD 
Ciprofloxacin 
3 other FQ 
surface water SPE - 
1.44 
pM 
[141] 
coupled-column 
LC-FLD 
Ciprofloxacin 
8 other FQ 
surface water Online SPE 60–950 pM 60 pM [142] 
 
* instrumental quantification limit calculated as absolute amount injected in pg (injection volume 200 µl) 
Abbreviations: SPME – solid phase microextraction; SSPE – selective solid phase extraction; MMIP - 
magnetic molecularly imprinted polymer.  
 
In conclusion, chromatographic methods have a high analytical power in the detection of 
low weight molecular species for clinical and environmental applications. However, one should 
not forget that the analytical methods based on the chromatographic separation require a large 
initial capital investment and, later, high service costs. There is a lack of standardization, 
therefore results from different laboratories are not comparable. Furthermore, they are 
sophisticated methods requiring qualified staff and are not suitable for on-site detection. 
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1.3.2 Surface Enhanced Raman spectroscopy as alternative detection method 
 
For the identification of drugs in complex matrices, the analytical method has to yield 
great specificity. Vibrational spectroscopies are well known for giving molecular specific 
information. Both vibrational infrared (IR) and Raman spectroscopy take advantage of the 
vibrational modes of molecules, which result from the interaction of the sample with 
electromagnetic radiation. IR spectroscopy is based on the absorption of the near and mid-IR 
electromagnetic radiation by molecules undergoing a change in the dipole moment during 
vibration. In the case of Raman spectroscopy, molecules, which present a change in polarization 
during vibration, inelastically scatter the electromagnetic radiation. Water, one of the main 
constituents of the biological and environmental samples, has high absorption in the IR range, 
whereas its scattering cross section is very low. Thus, for analysis of aqueous samples Raman 
spectroscopy is preferred instead of IR absorption spectroscopy. 
The first experimental evidence for the inelastic light scattering was given by C. V. 
Raman and K. S. Krishnan [143] in 1928. Since its discovery, Raman spectroscopy found a large 
variety of applications in material and life sciences. The effect is based on the inelastic scattering 
of light by molecules. When an electromagnetic radiation (ω0)
1
, i.e. photons of a laser beam, 
interacts with the molecules of a sample, besides the elastically scattered photons (referred to as 
Rayleigh scattering) also photons with a modified frequency (ωs=ω0-ωvib Stokes scattering and 
ωs=ω0+ωvib anti-Stokes scattering) are scattered [144]. The Raman effect is a two photon process 
[145], where a photon with energy ħω0 is annihilated and a new photon with energy ħωs (or 
ħωAS) is created as a consequence of the radiation-material interaction. If the molecule is in the 
electronic ground state, the inelastic scattering process via a virtual state
2
 results in the energy 
loss of the incident photon and the scattering is referred to as Stokes Raman scattering [145]. On 
the other hand, if the electrons of the molecule are in a vibrational energy level of the ground 
electronic state, the inelastic scattering process via the virtual state leads to energy gain of the 
incident photons and the scattering is referred to as anti-Stokes scattering. 
 
 
                                                     
1
 ω0 is the angular frequency of the incident electromagnetic radiation. ω0=2πν0=2πc0𝜈0=2πc/λ0, where ν0 
is the frequency, 𝜈0 is the absolute wavenumber and λ0 is the wavelength of the incident radiation, whereas 
c0 is the speed of light in vacuum. 
2
 the virtual state is a mathematical construction of the quantum mechanical perturbation theory. 
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Enhanced Raman Spectroscopies 
 
The inelastic light scattering is a very weak process, thus only a very small amount of 
the incident photons will be inelastically scattered [145]. Consequently, the detection of analyte 
molecules present at very low concentration is limited. To overcome this drawback, different 
signal enhancement strategies can be applied. The two most commonly encountered techniques 
are resonance Raman spectroscopy and SERS. The resonance Raman effect appears when the 
incident electromagnetic wave has energy close to the energy needed for an electronic dipole 
transition within the molecule [145, 146]. The positions of the Raman bands are at electronic 
ground state vibrational frequencies, whereas the intensities are considerably enhanced (up to six 
orders of magnitude [146]) due to the electronic dipole transition [147]. However, the Stokes 
shift between the absorption and fluorescence of the molecule has to be big enough in order to 
avoid the overlapping of Raman bands with the fluorescence background.  
The SERS effect was first observed in 1974 by Fleischmann while recording the Raman 
spectrum of pyridine adsorbed on a roughened silver electrode [148]. Forty years later, 15% of 
the overall Raman publications are related with this topic (according to the numbers provided by 
the ISI Web of Science). The SERS technique gained popularity due to its high sensitivity. 
SERS combines the Raman technique with the plasmonic properties of nanostructured coinage 
metals. Its high signal enhancement originates from two mechanisms: the electromagnetic 
enhancement (EM) and the chemical enhancement (CE) [34-36, 149, 150].  
The main driving force of surface enhanced spectroscopies is the plasmon, “a quantum 
quasi-particle representing the elementary excitations, or modes, of the charge density 
oscillations in a plasma” [151]. When, i.e., a spherical metallic particle interacts with an 
electromagnetic radiation with (λ>>d)3, polarization within the nanoparticle is induced. If the 
frequency of the incident wave (ω0) matches the oscillation frequency of the charge density, the 
particle acts as a dipole antenna and emits light. The plasmon resonance condition for a spherical 
nanoparticle is fulfilled when (ϵ(λ)=-2ϵm)
4
. This condition is only partially met because of the 
presence of the imaginary part, Im(ϵ(λ)), of the dielectric function. The resonant excitation is 
associated with a local field enhancement referred to as the dipolar localized surface plasmon 
polariton (LSPP) [151]. Furthermore, under appropriate experimental conditions (Kretschmann 
                                                     
3
 λ is the wavelength of the incident electromagnetic radiation, whereas d is the diameter of the spherical 
nanoparticle. 
4
 ϵ(λ) represents the dielectric function of the nanoparticle, whereas ϵm is the dielectric constant of the 
surrounding medium. 
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or Otto configuration) propagating surface plasmon polaritons (PSPP) can be also induced at the 
interface between a dielectric and a metallic layer [151]. The increased local electric field 
(Eloc(ω0)) caused by the dipolar LSPP or PSPP is the source of the signal enhancement and the 
basis of the EM mechanism. If a molecule is in the vicinity of the metallic particle supporting 
LSPP, first an increased scattering intensity will arise because of the induced dipole moment 
given by μind=αmoleculeEloc(ω0) instead of μind=αmoleculeE0(ω0). Furthermore, the inelastically 
scattered light (ωs) will also be enhanced if the frequency of the scattered electromagnetic wave 
is in resonance with the plasmon of the metallic particle. Therefore, the overall SERS intensity 
will be given by following mathematical relation: ISERS=Iloc(ω0)Iloc(ωs)=|Eloc(ω0)|
2
|Eloc(ωs)|
2 
[40]. 
For incident electromagnetic waves having wavelengths in the blue and green region ωs= ω0-
ωvib≈ ω0 and the approximation ISERS≈|Eloc(ω0)|
4
 is valid [150, 152].  
The EM mechanism was proved to account for signal enhancements up to 10
11
 [153]. 
However, factors of 10
14
-10
15
 [33, 154, 155] have been reported in literature. The additional 
signal gain was attributed to the CE mechanism. Three different processes have been suggested 
to contribute to this: (1) chemical interaction of the nanoparticle and molecule in the electronic 
ground state; (2) resonant excitation of the charge-transfer process between the molecule and the 
nanoparticle; and (3) the resonance Raman enhancement [156, 157]. In the first case, the 
molecule is not covalently bound to the surface of the nanoparticle. However, the presence of the 
metal perturbs the electronic structure of the analyte inducing a slight change in its electronic 
distribution. In the second case, it was shown, depending on the relative energies of the Fermi 
level of the nanoparticle, the highest occupied molecular orbital and the lowest unoccupied 
molecular orbital of the molecule, charge transfer from molecule to metal or from metal to 
molecule can occur. Lastly, the resonance Raman enhancement coupled with the presence of 
nanoparticles, also referred to as surface enhanced resonance Raman spectroscopy (SERRS), it is 
based on matching the energy of the incident radiation with the energy needed for an electronic 
dipole transition within the molecule.   
As mentioned above, Raman bands are observed for those vibrational modes of the 
molecules that present a change in their dipole electric polarizability during vibration. However, 
under SERS conditions, vibrational modes forbidden by this selection rule have been reported 
[158, 159]. The unusual phenomenon was associated with the strong evanescent character of the 
local electromagnetic field at the surface of the metallic nanoparticles. When the size of the 
molecule to be detected is comparable with the local electric field gradient, the excitation of 
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multi-pole transitions becomes significant. The effect is referred to as the gradient-field effect or 
“quadrupole-SERS” [35, 160]. 
A second effect influencing the SERS spectrum is the orientation of the molecules on 
the metallic surface; effect known as surface selection rules [161]. According to these rules, 
when the polarizability of the local electric field is perpendicular to the surface, Raman modes of 
the adsorbed molecule with strong polarizability tensor component normal to the surface are 
selectively enhanced as compared with the Raman modes with strong parallel polarizability 
tensor components [161, 162]. Therefore, the overall SERS spectrum will be influenced by the 
orientation of the molecule and will differ from the reference Raman spectrum.   
 
SERS active substrates  
  
Silver and gold are the most commonly used metals for fabricating SERS active 
substrates. Silver is preferred when the aim is focused on high signal enhancement, whereas gold 
is chosen mainly because of its higher stability under atmospheric conditions. The difference 
between the strength of the LSPP of the two metals can be explained by comparing their 
dielectric functions. The real part of the dielectric function (Re(ϵ(λ))) is comparable because of 
the similar electronic densities of the two metals [151]. However, gold has a considerably higher 
absorption at λ<600 nm associated with a higher magnitude of the Im(ϵ(λ)) because of the inter-
band electronic transitions [163]. Therefore, for this spectral region, the strong LSP resonances 
of small gold nanoparticles are significantly damped. Gold particles with diameter > 50 nm 
present resonances in the λ>600 nm spectral region. However, at this dimensions also radiation 
damping starts to become important and it limits the strength of the LSP resonance [164].  
SERS active nanostructures can be synthesized in numerous ways, such as bottom-up 
methods for obtaining metal colloids or core-shell nanoparticles, self-organization or template-
assisted methods and top-down processes [42]. Despite of the great technological advances, 
metallic colloids represent the most simple and accessible route to SERS. The Ag nanoparticles 
prepared by the Lee-Meisel protocol [165] are the most widely used ones. Here, silver nitrate is 
reduced by sodium citrate at water boiling temperature. An alternative to this, is to synthesize 
nanoparticles via the Leopold-Lendl protocol [81]. The reaction takes place at room temperature 
by reducing silver nitrate with hydroxylamine hydrochloride in the presence of sodium 
hydroxide. Both protocols yield silver nanoparticles with diameters between 30-40 nm and a 
plasmonic resonance maximum around 410 nm. The direct optical extinction measurements 
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(UV-Vis spectroscopy) are one of the simplest methods to characterize metallic colloidal 
solutions [43]. The UV-Vis spectra exhibit one, or sometimes more, bands associated with the 
resonant wavelength of the LSP resonances of the substrate. However, the connection between 
the extinction spectrum and the magnitude of the electromagnetic SERS enhancements is in 
general indirect. For example, the single particle LSP resonances present a strong extinction 
band despite their no or very low SERS signal enhancement [44], whereas coupled-LSP 
resonances originating from two or more closely located nanoparticles (“hot-spots”) have a weak 
extinction spectrum despite of their large local field enhancement. 
 
SERS applications 
 
Throughout the last years, SERS advanced from being a technique mainly used to 
characterize molecule-metal interactions [166, 167] and detection of dye molecules in pure water 
[168, 169] to quantification of biomolecules in clinical and environmental samples [170-173] as 
well as the detection of biomarkers of various diseases [174, 175]. The clinical and 
environmental matrices have a rich chemical composition. Therefore, the target molecule to be 
detected will compete with the molecules of the complex matrices for binding sites on the 
metallic surface. Whole blood, plasma and serum represent the biggest challenge [25, 176], 
whereas urine samples and environmental samples are easier to handle.  
SERS measurements in blood samples were carried out mainly to discriminate between 
blood samples of patients having cancer and blood samples of healthy individuals [174, 175, 
177-180]. The number of reports focused on the SERS detection of drugs in blood is very low. 
Folic acid was detected in spiked blood serum diluted to 1% with water with a limit of detection 
of 9 nM [181] or in serum diluted to 80% followed by protein precipitation at 1 µM [182]. 
Paclitaxel, an anti-cancer drug, was quantified in spiked human plasma down to 10
-8
 M [183]. A 
recent publication [184] reported on the successful determination of MTX spiked in human 
serum. The employed SERS active substrates were prepared by depositing gold nanoparticles on 
paper by a dip-coating procedure for one week. Calibration standards were prepared by spiking a 
drug-free serum with MTX dissolved in phosphate buffered saline solution at a ratio of 1:4. The 
samples were deposited on the SERS active substrate by drop coating. The linear dynamic range 
was assessed to be between 0.1-150 µM. As mentioned in the previous sections, the number of 
developed assays for MTX quantification is very high. Thus, for a new method to be taken under 
consideration as an alternative detection technique, it has to provide good analytical 
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performances, lower costs, and easy access. The preparation of SERS active substrates by long 
dip-coating procedures presents a great handicap. In one other report, levofloxacin lactate was 
detected in mouse blood via SERS and an optical fiber nanoprobe coated with gold nanoparticles 
[185]. The authors compared the detection of the molecule in a conventional setup by employing 
the gold nanoparticles in colloidal solution as SERS substrate with the detection capabilities of 
the fiber nanoprobe. However, the publication does not assess the analytical performances of the 
method and no details regarding the detected concentrations in blood are provided. Concerning, 
nitroxoline detection in biological fluids, no literature is available on this topic up to date. 
The complexity of urine samples as compared to the blood ones is considerably reduced. 
Water is the main component, followed by urea and creatinine. The protein content is very low 
in the case of healthy individuals, therefore the number of interferences is considerably reduced 
as compared to blood. Endogenous molecules, such as creatinine [30, 31, 186, 187] and uric acid 
[28, 32, 188], drugs, i.e. opioid tramadol [172], benzodiazepines [11], 3, 4-methylenedioxy 
methamphetamine [173, 189, 190], and tobacco-related biomarkers [26, 171] were successfully 
detected by SERS in urine samples. MTX is strongly metabolized. Thus, its detection in urine 
samples is not feasible. On the other hand, antibiotics used for treating urinary tract infections 
are most often present in high concentrations in urine. Despite this fact, studies related with 
neither levofloxacin or nitroxoline detection have not been reported. Instead, moxifloxacin, 
another fluoroquinolone, was quantified by SERS and multivariate curve resolution on 
nanostructured gold surface [170]. However, the matrix was strongly diluted (to 1%) in order to 
obtain good results.  
 Environmental samples, especially surface water samples, present the lowest matrix 
complexity. However, the molecules to be detected are very different. Pesticides, polycyclic 
aromatic hydrocarbons, polychlorinated biphenyl, explosives, heavy metal ions, antibiotics, 
hormones, pathogens and many other compounds are considered as water pollutants [191]. 
Multiple SERS reviews summarize the successful detection of these molecules [37, 191-193]. 
Ciprofloxacin detection was reported by using various SERS substrates [39, 194-196]. The 
detection limits ranged from 1 nM in distilled water in the case of the core–shell structured 
magnetic molecularly imprinted polymers to 0.2 µM in the case of dendritic silver 
nanostructures. However, none of the publications proved the feasibility of SERS for detecting 
the molecule in environmental samples. 
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Quantitative SERS measurements 
 
The above reviewed studies were based on using dry, planar SERS substrates or metallic 
nanoparticles in colloidal solutions. In the first case, challenges appear because of the correct 
sample deposition on the substrate. Commonly, drop coating is practiced. This creates a 
heterogeneous layer of analyte molecules on the surface due to the coffee-ring effect yielding 
SERS signals with low reproducibility. When the substrates are incubated into the sample, the 
incubation time will strongly influence the final SERS results. On the other hand, metallic 
colloids need to be aggregated to create hot-spots. This can be achieved via: (1) the effect of the 
analyte itself acting as an aggregating agent by changing the surface charge of the nanoparticles, 
(2) the addition of a passive electrolyte such as KNO3, (3) the addition of an active electrolyte 
such as KCl or by (4) the addition of polymers or long-chain ions [43]. The aggregated metallic 
nanoparticles yield great signal enhancements, but the SERS spectrum of the molecule to be 
detected becomes dependent on the time elapsed between the induction of the aggregation and 
the measurement [45]. Furthermore, the mixing order, ratio and time lapse between mixing of 
the nanoparticles, the analyte solution, and the aggregation agent have a crucial influence on the 
SERS signal [56, 197]. All these parameters will yield a very poor reproducibility of the SERS 
signals of the molecules to be detected and will result in the impossibility to perform quantitative 
measurements. 
Various strategies have been developed to overcome these limitations. One of the 
approaches consists in the implementation of internal standards [24, 27, 52, 55, 198-202]. In 
order to have reliable results, the signal of the internal standard has to be influenced by the 
presence of the plasmonic nanostructures, yielding a SERS signal rather than just a Raman 
spectrum.  
A second approach to achieve reproducible measurement conditions combines SERS 
with microfluidic platforms. Microfluidics offers the great advantage of highly precise controlled 
manipulation of nanoparticle and sample solution and high sample throughput. Two different 
designs are available: the continues-flow and the segmented-flow approach [29, 50, 57]. In the 
first case, the SERS active nanostructures are generally immobilized on the surface of the 
microchannel, the sample is continuously pumped into the channel, while the detection is carried 
out on the surface of the channel wall. An alternative to this is the simultaneous flow of the 
nanoparticle solution and sample. Nevertheless, because of the continuous flow, analyte 
molecules can stick to the channel walls and the reliable detection is inhibited by the “memory 
Analytical Methods for Drug Detection – current state of research 
 
25 
 
effects”. Additionally, the immobilization of SERS active substrates in the channel walls is not 
trivial.  
In the second approach, also referred to as droplet based microfluidics, the solutions are 
dispensed into individual droplets surrounded by an immiscible liquid phase. Therefore, the 
liquid of interest does not wet the channel walls and cross contamination can be prevented as 
long as the molecules do not diffuse to the carrier fluid [58]. The flow of the liquids is controlled 
either by volume, i.e. using syringe pump systems, or by pressure, i.e. hydrostatic reservoirs. 
The droplets can be trapped, sorted, mixed, or split, based on the specific experimental 
requirements [58, 203]. Commonly, the employed nanoparticles are previously synthesized and 
then injected into the chip, but also the in-situ nanoparticle synthesis has been reported [38, 41, 
204, 205]. This offers a great advantage because the challenges represented by batch-to-batch 
reproducibility and colloidal solution aging effect can be avoided. Furthermore, each droplet can 
be considered as a micro-cuvette or a micro-reactor. The colloids are mixed with the analyte in a 
reproducible way and by mounting the chip on the microscope stage and fixing the focus point 
the aggregation time can be easily controlled.  
Traditional quantitative measurements are carried out by first establishing a calibration 
curve. Generally, each analyte will give different signals; therefore, the analytical response has 
to be measured for each analyte at known concentrations using standard solutions. Based on 
these measurements, calibration curves are constructed using the method of least squares and the 
concentration of the analyte in the unknown sample can be determined. However, this procedure 
will yield correct results only if the chemical composition of the standard solutions and the 
unknown sample is identical. If this is not the case, the so called matrix effects will inhibit the 
correct prediction of the unknown concentration. Furthermore, in the case of SERS, because of 
the batch-to-batch quality variations of the plasmonic substrates, this strategy is not feasible.  
A solution to this problem is represented by the standard addition method (SAM). Here, 
all analytical measurements, including the calibration curve, are performed using the sample 
itself and the slight variation between colloid batches will have no impact on the final results.  
The SAM experiments are carried out as follows: (1) equal amounts of the sample are 
pipetted into several volumetric flasks, (2) increasing volumes of standard are added to each 
flask, (3) the content of each flask is diluted to the same volume (Figure 1) [206]. Therefore, 
every flask contains the same concentration of the unknown and different concentrations of the 
standard. The standard solutions contain the same analyte as the one to be quantified. The 
number of flasks minus one represents the number of the standard addition steps (SAS). The  
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Figure 1. The standard addition method. 
 
signal intensity for all flasks is measured and plotted as shown in Figure 1. The intercept of the 
linear regression with the x axis will give the concentration of the analyte in the unknown 
sample and it is the ratio of the intercept at y=0 and the slope of the regression [207]. 
For the SAM to work, two conditions have to be fulfilled: (1) the signal of the molecule 
in the unknown sample has to be detectable by the instrument and (2) the signal intensity as 
function of the concentration has to be linear. In order for the analyte in the unknown sample to 
generate a signal, its concentration must be above the detection limit (referred to also as the 
lower LOD). According to the IUPAC definition, the LOD is equal to the signal of the blank 
plus three times its standard deviation. Another defined quantity is the lower LOQ, which is 
commonly defined as the blank plus ten times its standard deviation, and represents the smallest 
amount that can be measured with reasonable accuracy. The linear range of an analytical method 
is the analyte concentration range over which the measured signal is proportional to the 
concentration. The dynamic range, on the other hand, represents the concentration range over 
which there is a measurable response of the signal to the presence of the analyte, even if the 
response in not linear. 
Multiple SERS studies combined with SAM have been published in the last five years. 
Buserilin was determined in human urine [208], 4-aminophenol in a pharmaceutical formulation 
[209], melamine in milk [210], nicotine in artificial urine [171], moxifloxacin in urine [170], 
congo red [211] and uric acid [28].  
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In conclusion, the combination of fingerprint specificity of Raman spectroscopy, high 
sensitivity of SERS, reproducible and automated measurement conditions offered by LoC 
platforms with the quantification provided by SAM yields a powerful analytical tool for the 
detection and quantification of both clinical and environmental relevant molecules. Furthermore, 
thanks to the development of portable Raman setups, the costs of LoC-SERS platforms is 
significantly lower as compared to chromatography setups. The LoC-SERS measurements can 
be easily carried out even in the absence of a microscope, just by using i.e. a fiber probes for 
focusing the laser beam in the microfluidic channels and collecting the inelastically scattered 
light. Furthermore, the footprint is small facilitating the on-site analysis.      
 
 
 
 
    
Own research results 
 
28 
 
1.4 Own Research Results 
    
1.4.1 Influence of molecule-metal interactions on the SERS signal 
 
 It is a prerequisite to first understand the nature of the Raman and SERS spectra of 
molecules before detecting and quantifying them in complex matrices. During the thesis, the 
interaction of four different drugs with the surface of the silver colloids was addressed. 
Reference Raman spectra of the drugs in the powder form were compared with the recoded 
SERS spectra in cuvettes of the molecules solved in purified water. Based on previously 
published vibrational characterization performed with density functional theory calculations and 
by taking into account the surface selection rules described in the previous chapter, the 
orientation of the molecules on the metallic surface is proposed. However, in order to confirm 
the validity of the suggested orientations further calculations are required, which are beyond the 
purpose of the present thesis. 
 The conformation of the antifolate drug MTX consist of two planar groups: one is the 
2,4-diaminoptreidine group and the second one is the (p-aminobenzoyl)-L-glutamat group. The 
molecule has both hydrophobic (the pteridine and the benzoyl group) and hydrophilic 
(carboxylate groups) structural groups. In purified water MTX is just sparingly soluble. 
Therefore, during the experiments presented in reference [IH1] the SERS spectra were recoded 
under basic pH conditions. The reference Raman spectrum presented in Figure 3 [IH1] has a rich 
fingerprint in the 200-2000 cm
-1
 spectral range. SERS spectra were obtained by using citrate 
reduced Lee-Meisel silver nanoparticles. After the nanoparticles were mixed with MTX solution, 
1 M KCl was added to induced the creation of hot-spots. Compared with the Raman spectrum, 
the SERS spectrum of MTX at pH 12 presents slight differences. Three different factors can 
cause this difference: (1) the molecule-metal interaction, (2) orientation of the molecule on the 
metallic surface and (3) the deprotonation of the molecule at the carboxylic moiety. Generally, 
molecules can interact with the silver surface either via the lone pair electrons of the nitrogen or 
oxygen atoms or via the π orbitals of the aromatic rings. In the case of MTX, possible adsorption 
sites are via the amino groups. This hypothesis is confirmed by the shift of the Raman band 
located at 1327 cm
-1
 and ascribed to the NH2 deformation by 19 cm
-1
 in the SERS spectrum as 
compared to the recorded Raman spectrum. Further observed differences were associated with 
the orientation of the molecule on the metallic surface. Namely, the disappearance in the SERS 
spectrum of the Raman band assigned to the C=N vibration of the pteridine ring suggest that this 
ring might be parallel with the metallic surface. Simultaneously, the ring breathing mode located 
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at 956 cm
-1
 of the aromatic ring presents a high SERS signal intensity. Based on the surface 
selection rules, when the in-plane ring vibrations are enhanced an upright orientation of the 
molecule is assumed, whereas in the case of the enhanced out-of-plane vibrations the molecule 
adopts a parallel orientation on the metallic surface. Therefore, the aromatic ring might be 
perpendicular on the surface. The suggested orientation is graphically illustrated in the inset of 
Figure 4 [IH1].  
 The MTX SERS study was carried out with Lee-Meisel nanoparticles [165]. The 
chemical reaction, during which silver nitrate is reduced by citrate, require water boiling 
temperature and it lasts for more than one hour. During my experiments, the synthesis was not 
always successful and the quality of the prepared colloids varied strongly among batches. 
Therefore, an alternative synthesis procedure was needed. The silver nanoparticles synthesis 
described in the Leopold-Lendl protocol [81] is carried out at room temperature by adding the 
silver nitrate solution to the hydroxylamine hydrochloride and sodium hydroxide solution under 
rigorous string. The reduction of the nanoparticles takes place instantaneously. The colloid 
batches prepared in this way were stable for more than half a year and the quality variation in 
between batches was not significant. Recorded UV-Vis spectra are shown in all subsequent 
publication [IH2-IH5]. Generally, the maximum of the extinction band was located ~408 nm and 
a full-width-at-half maximum of 80 nm indicates the creation of nanoparticles with a mean size 
of ~35 nm. 
 To the best of my knowledge, the first recoded SERS spectrum of levofloxacin was 
reported in the publication presented in the frame of the current Ph.D. thesis [IH2]. The 
backbone of the levofloxacin molecule is formed by the quinolone ring system having attached a 
fluorine atom and a piperazine moiety. The molecule has a zwitterion character at neutral pH due 
to the presence of both anionic and cationic groups. The reference Raman spectrum measured on 
powder and in a saturated aqueous solution (Figure 2 [IH2]) differ because, once the molecule is 
solved in water, the strong packing present in the crystalline form is destroyed, thus, also the 
polarizability of the molecule might change. As marker bands for the characterization of 
levofloxacin, the Raman signals at 1395 cm
-1
 (coupled vibration of the quinolone ring system + 
symmetric COO
-
 stretching) and 1614 cm
-1
 (C=C stretching) were chosen.  
  In the case of MTX the aggregation of the Ag nanoparticles was induced by the 
presence of KCl. Levofloxacin, however, presented a completely different behavior. When the 
molecule was added to the colloidal solution, the color of the nanoparticles changed. The 
intensity of the extinction band of the single LSP resonance diminished and a broad band at 
higher wavelengths appeared in the UV-Vis spectra (Figure 4 [IH2]) of the colloid-analyte 
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mixture. The most intense SERS signals were recorded when no additional aggregation agent 
was added to the mixture (Figure 3 [IH2]. In conclusion, levofloxacin itself is inducing the 
aggregation of the nanoparticles. Furthermore, the order of mixing of the nanoparticles with the 
analyte solution and KCl was shown to have a major significance. If KCl is added after mixing 
the nanoparticles with the levofloxacin solution, the SERS signal intensity is lower as compared 
with the case when no KCl is added. This might be because of an “over aggregation” of the 
nanoparticles. If the order is changed, and first the nanoparticles are aggregated and only 
afterwards levofloxacin is added, the two Raman marker bands are almost indistinguishable 
from the background at a concentration of 1 mM. This behavior might have two explanations. 
On one side, the chloride ions might block the free binding sites on the surface of the silver 
nanoparticles. On the other side, by pre-aggregating the nanoparticles, levofloxacin will 
adsorbed on the surface of the large aggregates instead of the gaps between the single 
nanoparticles. These features of levofloxacin will have a big influence on the detection of the 
molecule in the human urine samples. First, because the nanoparticles are aggregated by the 
antibiotic, the background signal originating from the molecules of the urine samples might be 
influenced by the aggregation degree of the plasmonic substrate. Second, the salt content will 
vary among the samples and thus, it can result in sample dependent, increased detection limits. 
 The interaction of levofloxacin with the metallic surface and its orientation was 
established based on the differences observed between the reference Raman and the SERS 
spectrum. First, the ratio of the two Raman marker bands is changing for the different 
measurements. An increase in relative intensity of the band located at 1395 cm
-1
 (due to the 
coupled vibration of the quinolone ring system and symmetric COO
-
 stretching) in the SERS 
spectra as compared to the Raman spectra might suggest an interaction via the oxygen atoms or 
the delocalized electrons of the COO
-
 group. Second, in the SERS spectrum of levofloxacin 
without KCl additions, a band appears at ~230 cm
-1
. This was ascribed to the Ag-O stretching 
vibration. Third, the enhancement of the Raman band located at 1554 cm
-1
 and assigned to the 
in-plane vibration of the quinolone ring system and the absence of the bands due to the out-of-
plane ring vibrational modes might suggest an upright orientation when no KCl is added. Upon 
KCl addition, this mode (at 1554 cm
-1
) diminishes in intensity, which might suggest a change in 
the orientation into a tilted configuration. The suggested orientation of the molecule is illustrated 
in Scheme 2 [IH2].     
 NTX is a quinolone derivative with an OH group bound to the carbon atom at the 8
th
 
position and a nitro (-NO2) group at the 5
th
 position (chemical structure in Figure 1 [IH4]). 
Generally, molecules can either physisorb or chemisorb on the metallic surface. In the first case, 
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the SERS spectra are very similar with the Raman ones, whereas in the second case, relative 
band intensity ratios change and the position of the bands is shifted. The recorded SERS 
spectrum of NTX is considerably different as compared with the reference Raman spectrum 
(Figure 1 [IH4]) indicating that the molecule might be chemisorbed on the metallic surface. 
More exactly, in the SERS spectrum the intensity of the Raman modes located ~840 cm
-1
 and 
998 cm
-1
 are significantly enhanced as compared with their intensity in the Raman spectrum. 
The two modes were assigned to the aromatic in- and out-of-plane C-H bending modes. 
Additionally, the intense C-O stretching band at 1313 cm
-1
 is downshifted by ~25 cm
-1
 and the 
C=N stretching mode at 1465 cm
-1
 is enhanced as compared to the Raman spectrum. A further 
prove for the chemisorption process is given by the following experiment. When the NTX 
solution is mixed with the mineral oil, later used as separation medium for LoC-SERS 
measurements, a certain amount of the molecule will diffuse from the aqueous solution to the oil 
phase because of the presence of hydrophobic groups in the chemical structure. This will lead to 
decreased SERS intensities in the subsequent measurements carried out with the LoC platform. 
However, if NTX is first mixed with the silver nanoparticles the addition of mineral oil does not 
lead to a SERS signal decrease. This happens due to the high chemical affinity of the molecules 
toward the metallic surface. This property of the molecule will have a major importance for its 
successful detection in complex matrixes. 
 Inconsistencies between available band assignments and the observed spectral changes 
make the determination of the molecule orientation hard to assess. Namely, both Raman modes 
at ~800 cm
-1
 and ~840 cm
-1
 were assigned to the C-H out-of-plane bending modes. In the SERS 
spectrum only the second band is selectively enhanced. The same was observed also for the 
bands ascribed to the C-H in-plane bending modes at 987 cm
-1
 and 1153 cm
-1
. Generally, it is 
expected that bands associated with the same vibrational mode will be equally influenced by the 
local electromagnetic field of the plasmonic structures. Because this is not the case, the 
vibrational modes of the molecules have to be newly calculated before a correct description of 
the orientation of NTX molecule on the Ag surface can be given.   
 The last investigated molecule in the frame of the thesis was ciprofloxacin. The 
antibiotic is a fluoroquinolone derivative; therefore, its chemical structure is very similar with 
the one of levofloxacin (chemical structure in Figure 1 (A) [IH5]). However, its water solubility 
at neutral and close to neutral pH is limited to ~0.2 mM. In the first part of the published work 
[IH5] the influence of the pH of the ciprofloxacin solution on its Raman and SERS spectra is 
discussed. At low pH, the protonation takes place at the amino group of the piperazinyl ring, 
whereas at high pH the carboxylic acid moiety is deprotonated. In the case of the Raman spectra 
Own research results 
 
32 
 
of saturated aqueous solution at pH 1 the spectral feature at 1362 cm
-1
 ascribed to the ring 
stretching vibration of the piperazinyl ring is downshifted by 17 cm
-1
 as compared to the Raman 
spectrum of the powder and the intensity of the band at 1452 cm
-1
 associated with the CH2 
deformation of the same ring is increased. Upon deprotonation, the relative intensity of the 
1382 cm
-1
 band assigned to the combined C=C and symmetric COO
-
 stretching is increased.  
 In the presence of the metallic surface the protonation/deprotonation state of the 
molecule plays a major influence on the molecule-metal interaction. The SERS spectra recorded 
at acidic pH are considerably weaker in intensity as compared with the SERS spectra of the basic 
solutions. For low pH values, the free electron pairs interact with the protons of HCl. Hence, 
they can no longer optimally bind to the Ag surface and the intensity is considerably lower than 
the one recorded at basic pH. Concerning the orientation of the molecule on the metallic surface, 
at acidic pH, the piperazinyl and cyclopropane ring might be in the close proximity of the 
metallic surface or their polarizability tensor has such an orientation that its zz components are 
perpendicular to the surface. This is suggested by the enhanced Raman modes in the high 
wavenumber region associated with the sp
3
 hybridized carbon atoms localized at these rings. 
When the molecule is deprotonated, the Raman band that is ascribed to the C=C stretching of the 
quinolone ring system at 1616 cm
-1
 in the Raman spectrum is shifted by 8 cm
-1
 compared to the 
band position in the Raman spectra of the saturated aqueous solutions. The shift may be caused 
by the interaction of the aromatic ring system with the Ag surface. Therefore, the deprotonated 
ciprofloxacin molecule probably adopts a flat orientation with interactions via the nitrogen 
atoms of the piperazinyl ring. As in the case of levofloxacin, ciprofloxacin also induces the 
aggregation of the nanoparticles yielding higher SERS intensities as compared with the case 
when additional aggregation agents were added. Thus, when ciprofloxacin measurements were 
carried out with environmental samples, no additional activation agent was added. 
 
1.4.2 Dynamic range and limits of detection of drugs in purified water 
 
 Reliable quantitative SERS measurements require reproducible and, ideally, automated 
measurement conditions. At the Leibniz Institute of Photonic Technology (IPHT), the 
Microfluidics Group developed a glass based microfluidic chip (chip design in Figure 2). Glass 
has a low Raman scattering cross section, therefore is an ideal material for manufacturing 
microfluidic chips for SERS measurements. Prior to the measurements, a silanization procedure 
is carried out to obtain hydrophobic channel walls. This will facilitate the successful creation of 
aqueous droplets in the continues phase of oil. The microfluidic platform has the following  
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Figure 2. Droplet-based microfluidic chip used for quantitative and semi-quantitative SERS 
measurements. 
 
operational units: a droplet generator where the aqueous solutions are dispensed into the flow of 
mineral oil via a T-junction, a dosing unit where further aqueous solutions are injected into the 
already existing droplet, two meander channels assuring an optimal mixing of the droplet 
content and a long measurement loop. Generally, through port 1-3 the analyte solutions and the 
solvent (purified water, simulated urine, urine or river water) are pumped, while the Ag 
nanoparticles and KCl, as aggregation agent, are injected via port 4 and 5. The flow rate of the 
continues phase was fixed at 9 nl/s, the sum of the flowrates at the droplet generator was 14 nl/s 
and at the dosing unit 11 nl/s. The various solutions are filled into glass syringes that are 
connected with the chip via Teflon capillaries. The software provided with the pump system 
(neMESYS Cetoni GmbH) controls the flow rates.   
 Throughout the studies included in the present thesis, different analyte concentrations 
have been defined. If not otherwise stated, the “in-droplet” concentration of the analyte is 
depicted in the graphs. This represents the concentration of the target molecule in the solution 
that will be mixed with the nanoparticles in the chip. The further dilution with the colloidal 
solution and KCl is not considered. A second concentration, referred to as the “urinary” 
concentration, is used to express the concentration of the drug in the clinical sample, before its 
dilution with water. Because, none of the urine samples originated from individuals under 
medical treatment with levofloxacin or NTX, the antibiotics were artificially added in form of 
aqueous solution to the urine samples.  
 During the thesis, the dynamic ranges and LODs of the LoC-SERS technique were 
assessed for MTX, levofloxacin and NTX solved in purified water. Stock aqueous solutions 
were prepared for each analyte. By varying the flowrates of the analyte containing solution and 
purified water different in-droplet concentrations were obtained. 
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In the case of MTX the measured concentrations ranged between 0.16 µM to 100 µM. In 
Figure 5 [IH1] the mean SERS spectra and their double standard deviation for selected 
concentrations are illustrated. For data visualization, the Lorentz fitted peak area of the Raman 
band at 965 cm
-1
 assigned to the ring breathing mode of the aromatic ring perpendicularly 
orientated on the metallic surface was plotted as function of the in-droplet concentration. Based 
on Figure 6 [IH1] and the definitions given in the previous section, the achieved LOD is 
0.17 µM, the linear range spans from 0.2 µM to 2 µM and the dynamic range is between 0.2 µM 
to 10 µM. When the in-droplet MTX concentration exceeds 10 µM, the peak area of the Raman 
marker band does not increase with the increment of the concentration. This phenomenon is 
referred to as “the poisoning effect”. The number of free binding sites on the surface of the 
metallic nanoparticles is limited. When the concentration of the molecules exceeds a given, 
analyte dependent, threshold the further addition of molecules will not yield a signal increment. 
A second parameter playing an important role is the evanescent character of the local 
electromagnetic field. The SERS intensity scales with ~r
-12
, where r is the distance from the 
surface. Therefore, SERS is a truly surface sensitive technique and only the molecules in the first 
layers contribute to the measured signal. The analytical performances offered by LoC-SERS are 
theoretically sufficient for monitoring the MTX levels for patients undergoing high-dosage MTX 
treatments. More exactly, the MTX concentration at 42 h from the start of the treatment should 
be at most 1 µM. High risk toxic effects can occur at concentrations higher than 10 µM. 
Therefore, the clinically relevant concentration ranges from 1 to 10 µM. However, MTX 
concentrations have to be determined in human plasma or serum and this will bring further 
challenges due to the increased complexity of the matrix. The aim of the present thesis was 
directed toward the quantification of antibiotics in human urine and in river water sample. Thus, 
no further analysis was carried out for MTX.   
 In-droplet levofloxacin concentrations in purified water were measured in the 1-100 µM 
concentration range. In Figure 5 [IH2] the recorded mean SERS spectra of 15 differently 
concentrated solutions are depicted, while Figure 6 [IH2] shows the integrated peak area of two 
Raman bands. The Raman band at 1395 cm
-1
 was ascribed to the coupled quinolone ring system 
and symmetric COO
-
 stretching vibrations, while the one at 230 cm
-1
 to the vibration of Ag-O. 
For low levofloxacin concentrations, the peak areas of both signals exponentially increase, 
whereas at 20 µM the saturation regime appears. Based on the spectroscopic characterization of 
the levofloxacin molecule described in the previous section, the molecule interacts with the 
metallic surface via the carboxylate group and the band at 230 cm
-1
 appears because of the 
binding process. Therefore, the Raman mode at 230 cm
-1
 band is due to the levofloxacin  
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Figure 3. Peak area of the Raman modes of levofloxacin and their ratio. 
 
molecules in the first layer on the surface of the metallic nanoparticles, whereas the intensity of 
the 1395 cm
-1
 is increasing also due to the molecules present in the upper layers, but still located 
in the hot-spots. Because of these two different underlying mechanisms, the Raman band 
ascribed to the Ag-O vibration was implemented as internal standard. After the normalization 
procedure, the linear analytical response was significantly improved and it ranged between 
0.8 µM to 15 µM with a detection limit of 0.8 µM. The normalization also improved the relative 
standard deviation from ~10 % to ~2 %. This proves that the signal of the chosen internal 
standard is influenced by the LSP field and can compensate for variations induced by the 
heterogeneity of the field magnitude at different hot-spots (Figure 3 compares the variation of 
the peak area of the two selected bands and of their ratio). Urinary levofloxacin concentrations 
range between 1.38 ± 0.68 mM (after 4h from treatment administration) to 7 ± 5 µM (after 72 h). 
Thus, LoC-SERS has high potential for monitoring the clearance of levofloxacin.  
 The MIC values of NTX against uropathogens are between 10 to 40 μM. To assess the 
LOD of NTX solved in purified water concentrations between 1 µM to 100 µM were measured 
by the LoC-SERS setup [IH4]. The characteristic Raman bands of NTX can be clearly identified 
at 2.5 μM concentration in the mean SERS spectrum showed in Figure 2 [IH4]. The Raman band 
associated with the C-H out-of-plane bending mode at 840 cm
-1
 was integrated with the Simpson 
rule and the peak areas are plotted in the same figure. The achieved detection limit is 2.5 μM, 
which is five times lower than the required sensitivity. The signal showed a linear dependency as 
function of the concentration for the 2.5-10 μM range, while the dynamic range extends up to 
85 μM. At this concentration the previously mentioned poisoning effect appears. 
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 In conclusion, the three drugs, MTX, levofloxacin and NTX, were successfully detected 
in purified water, with good sensitivity and sufficient dynamic range for clinical applications. In 
the next sections the challenges brought by the complexity of biological and environmental 
samples will be addressed.  
 
1.4.3 Complex matrix and its challenges for drug detection  
 
 The detection and quantification of one single molecule out of a complex matrix can be 
similar with finding a needle in a haystack. Especially, when the SERS active substrates are not 
beforehand functionalized to capture one specific molecule. One of the objectives of the thesis 
was directed toward assessing the capabilities and limitations of the LoC-SERS technique using 
conventional, easy to prepare colloidal nanoparticles, to detected and quantify antibiotics used 
against uropathogens in human urine and environmental samples. But before this, an artificial 
matrix mimicking human urine samples was investigated to get insights into the parameters 
influencing the overall SERS signal. For this, levofloxacin was chosen as test molecule and the 
Raman band at 1395 cm
-1
 was used as marker band for discussing the effect of various 
parameters.  
 The artificial urine was prepared according to an already published protocol [81] and 
contained the following chemical compounds: 13.72 mM calcium chloride, 34.21 mM sodium 
sulfate, 5.92 mM magnesium sulfate, 85.99 mM ammonium chloride, 5.46 mM sodium citrate, 
17.05 mM sodium dihydrogen phosphate, 162.71 mM potassium chloride, 23.69 mM sodium 
chloride, 832.5 mM urea and 19.44 mM creatinine [IH3]. The SERS spectrum of levofloxacin 
solved in the artificial urine vs. purified water (Figure 1 [IH3]) presents different relative band 
intensities and decreased “absolute” intensity. Artificial urine has a pH value of 5, thus, this 
might cause the slight reorientation of the molecule on the silver surface and consequently, the 
different relative band intensities. The overall intensity of the SERS spectrum of levofloxacin 
solved in artificial urine may be affected by (1) “over aggregation” of nanoparticles and (2) 
competition between analyte and the molecules of the complex matrix for the free binding sites 
on the silver surface. To test the two factors, experiments were carried out to find out which of 
the components of the complex matrix has the highest influence on the SERS spectrum of 
levofloxacin. According to the results summarized in Figure 2 (A) [IH3], the presence of various 
salts causes the strongest signal decrease, while the addition of urea and creatinine leads to 
further intensity losses. Therefore, it is expected that the LOD and the dynamic range of LoC-
Own Research Results 
37 
 
SERS for levofloxacin detection will strongly vary among individuals due to the various osmotic 
concentration of the urine samples. 
 Generally, before chromatographic separations, the biological fluids are diluted with the 
mobile phase in order to reduce the matrix effects. The same sample preparation step was also 
carried out for our studies. In Figure 2 (C) [IH3], the peak area of the Raman mode at 1391 cm
-1
 
as well as the peak area of the band located at 990 cm
-1
 and ascribed to the urea molecule are 
plotted. The peak area of the later Raman band is increasing for increasing amount of artificial 
urine, whereas the former one is increasing with decreasing in-droplet concentration. This 
means, that by decreasing the concentration of the salts and other interfering molecules, the 
signal of the target molecule is inversely proportional with its concentration and the LOD value 
of the technique can be improved. However, one should be careful with the extent of dilution, as 
too strong dilution might lead to an analyte concentrations below the detection limit and useful 
information concerning the spectral signature of the complex matrix can be also lost.  
 SERS signals of molecules are generally aggregation time dependent. For optimal 
results the influence of the time lapses between colloid-analyte mixing and the measurement 
time point was assessed. For levofloxacin solved in artificial urine a short aggregation time 
yields the best results both for signal intensity and relative standard deviation (Figure 2 (B) 
[IH3]). 
 By taking into consideration all parameters affecting the SERS signal, concentration 
dependent LoC-SERS measurements were performed for levofloxacin amounts between 
0.05 mM and 1 mM. Furthermore, the reproducibility of the measurements was also tested by 
repeated spectra acquisition on different days and with different chips. The analytical 
performance of the method can be summarized as follows: (1) for a not diluted matrix the LOD 
was ~0.1 mM and the dynamic range between 0.1 mM - 1 mM, while (2) for the diluted matrix 
(57% artificial urine) the detection limit was improved to 0.055 mM and the dynamic range was 
extended accordingly towards lower concentrations (Figure 3 (A) [IH3]). The signal 
reproducibility was good even when the SERS spectra were recorded on different days with two 
different chips.  
 In the case of SERS measurements done for levofloxacin dissolved in purified water, the 
Raman mode ascribed to the Ag-O stretching vibration was implemented as an internal standard, 
yielding great linear range and lower relative standard deviations. In the presence of artificial 
urine the position of this band is redshifted by 10 cm
-1
, which indicates the adsorption of 
additional chemical species on the metallic surface. Despite this, when employing this band as 
an internal standard, once again improved linear dynamic range is achieved with an increased 
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goodness of fit from 0.96 to 0.99 over the whole measured concentration range. A possible 
explanation for this might be that while the concentration of the molecules of the complex 
matrix is constant during the measurements, the concentration of the target molecule is 
increasing. Thus, the intensity of the Raman band at low wavenumbers is also increasing. 
In conclusion, as compared with the acquired data for levofloxacin dissolved in purified 
water, the LOD dropped from 0.8 µM to 0.055 mM. This is almost two orders of magnitude 
higher and it can be associated once, with the competition between the molecules at the silver 
surface, and second, with the high salt content in the matrix. Therefore, for human urine samples 
the SERS signals of antibiotics will strongly vary between patients, and even in between samples 
collected from the same patient at different time points, and traditional quantitative 
measurements will lead to unreliable results.  
  
1.4.4 Human urine as matrix for antibiotic detection 
 
 Human urine samples used as complex matrix for the present thesis were either 
randomly collected from a healthy volunteer or received from the Institute of Medical 
Microbiology, University Hospital Jena. In the second case, the samples are left over volumes of 
routine analysis and were anonymized. In total, five samples originating from the healthy 
volunteer, six individual samples and three pooled samples from patients were included in the 
study. Neither the healthy volunteer nor the patients have undergone medical treatment with 
levofloxacin or NTX. As sample clean-up step, a simple filtration was carried out with a 
polyvinylidene difluoride syringe filter having a pore size of 0.22 µm in order to remove cells 
and debris. After filtration, the samples were diluted with water or spiked with the appropriate 
amount of drug solved in water. The degree of the dilution was decided based on observed 
experimental parameters. More exactly, the affinity of NTX toward the silver nanoparticles is 
considerably higher as compared with the case of levofloxacin. Therefore, the extent of the 
effect of the matrix on the SERS spectrum of the two molecules will differ. As a consequence, 
the matrix was diluted to 21 % for levofloxacin and 70 % in the case of NTX. However, because 
of the received low volume of urine samples originating from patients, for LoC-SERS-SAM 
measurements carried out with NTX, the samples had to be diluted to 50% in order to have 
enough sample volume for performing measurements.  
 The pH values and the osmotic concentration of human urine samples vary strongly 
among individuals. Thus, it is expected that the SERS signals will vary accordingly. By 
comparing the mean SERS spectra of the blank urine samples diluted with water, shown in 
Figure 4 [IH3] and in Figure S6 [IH4], the first observation made was that the overall intensity 
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of the signal is significantly influenced by the pH of the urine. Namely, the samples having an 
acidic pH show a considerably weaker SERS signal when compared with the neutral ones. 
According to the previously reported publications and due to the high abundance of urea in urine 
samples, a strong Raman mode around 990 cm
-1
 is expected. However, the samples included in 
the thesis show only a very weak signal in this spectral region. Instead, all spectra contain 
Raman modes at 485 cm
-1
, 637 cm
-1
 and 1123 cm
-1
 ascribed to the vibrational modes of the uric 
acid molecule. Furthermore, the spectral feature in the 1350-1380 cm
-1
 spectral range was 
assigned to the pyrrole half-ring symmetrical stretching within the hem molecule.  
 In the case of levofloxacin, spiked urine samples, three individual and three pools, with 
urinary concentration between 0.45 mM and 1.8 mM were measured. This concentration range 
was chosen according to the expected levofloxacin amounts in human urine after 4h from 
administration. Despite the rich Raman signature of the urine, the Raman characteristic bands of 
levofloxacin located at 1395 cm
-1
 and 1616 cm
-1
 are clearly distinguishable (Figure S7 [IH3]) for 
all samples. However, as earlier predicted, because levofloxacin is inducing the aggregation of 
the silver nanoparticles, the intensity of the Raman bands ascribed to the molecules of the 
complex matrix are influenced by the presence of the molecule. In order to rule out the influence 
of the different aggregation degree, the Raman mode located at 637 cm
-1
 and assigned to uric 
acid was employed as an internal standard.  
The Raman marker bands of levofloxacin are located in the same spectral range as the 
ones originating from the vibrational modes of the molecules of the complex matrix. Therefore, 
the analytical performance of LoC-SERS for levofloxacin detection in human urine samples was 
assessed by multivariate analysis instead of the univariate approach. For this, principal 
component analysis was combined with partial least square (PLS) regression. The normalized 
data was divided into two datasets. The first set was used for training the PLS model; model 
further applied for the prediction of the concentration values of the second dataset. According to 
Figure 5 ([IH3]), the dynamic linear range covers the whole measured concentration range and 
the lowest measured concentration, 0.45 mM, is above the LOD of the technique. Based on the 
mean SERS spectra and on the root mean square error of prediction of the PLS method, 
concentrations comparable to that obtained for levofloxacin solved in artificial urine are 
detectable. Therefore, the chemical composition of the chosen artificial urine successfully 
simulates the human urine samples.  
In the case of NTX, urinary concentrations below 8 mg/l (42.1 µM) are considered as 
susceptible concentrations, whereas for NTX amounts above 16 mg/l (84.2 µM) bacteria will 
develop resistance. In a first run of the experiments, urinary concentration dependent LoC-SERS 
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measurements were performed with three randomly collected urine samples of a healthy 
volunteer. The measured concentrations were between 4.28 µM and 42.8 µM. As it was foreseen 
by the results obtained when NTX was detected in purified water, the chemical affinity of the 
molecule toward silver facilitates its detection at concentrations as low as 4.28 µM. The 
characteristic Raman modes in the 1000-2000 cm
-1
 spectral range are strongly convoluted with 
the Raman bands of the blank urine samples. Nevertheless, the signal at 840 cm
-1
 is situated in a 
background free region and the LOD was calculated based on the integrated peak area of this 
Raman mode. According to Figure 3 [IH4], the achieved LOD was ~3 µM. This value is 
comparable with the one calculated for the case when NTX was solved in purified water (LOD 
~2.5 µM). Therefore, the molecules of the complex matrix do not inhibit the efficient adsorption 
of NTX on the surface of the silver nanoparticles. Beside good sensitivity, the LoC-SERS 
method also offers sufficient linear analytical response. For all three measured samples, a linear 
range over the whole measured concentration range was achieved.  
Up to now, it was shown that LoC-SERS can detect drugs in human urine samples, and 
depending on the characteristics of the molecules the sensitivities differ. However, the question 
how to determine the concentration of a drug in clinical samples has not been addressed. As 
discussed before, the traditional quantitative analysis with a priori established calibration curves 
is not feasible for SERS applications. The first impediment is the batch-to-batch reproducibility 
of the nanoparticles. Although we have shown that the Leopold-Lendl nanoparticles are 
providing reproducible SERS signals (Figure S9 [IH3]) the aging of the colloidal solution can 
influence the results. The second factor is represented by the high inter-individual variability of 
the chemical composition of clinical samples. Therefore, the combination of LoC-SERS with 
SAM is the most feasible approach for quantitative measurements. To demonstrate this, NTX 
was chosen as model analyte.  
None of the individuals consumed NTX before urine sample collection. Thus, “real” 
clinical samples had to be simulated by first spiking human urine (250 µl) with a small volume 
(76 µl) of highly concentrated (~70 µM) NTX aqueous solution. Therefore, the “unknown” NTX 
urinary concentration to be determined with LoC-SERS-SAM was ~ 21 µM (~4 mg/l). For each 
sample (two from a healthy volunteer and five patients), four SAS were prepared by adding 
purified water or/and NTX standard solution in different volumes. Additionally, the urine 
sample diluted only with water, without NTX, was also measured. These spectra were used as 
negative control to assess the correctness of the model. The “unknown” concentration was 
predicted with uni- and multivariate statistical analysis. In the first case, the estimation was 
made based on the calculated peak area of the NTX characteristic band located ~840 cm
-1
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(Figure 4 [IH4]). In the second case, multivariate curve resolution (MCR) combined with 
alternating least square regression (ALS) was applied. The predicted values were between 11.6 
and 26.4 µM in the case of the univariate analysis (Table S3 [IH4]), whereas for the MCR-ALS 
approach the concentration varied between 11.3 and 27.9 µM (Table S5 [IH4]). The mean 
absolute percentage error was ~21 % for both statistical methods. However, in the case of MCR-
ALS the “unknown” concentration of four out of seven samples was predicted with a relative 
error below 10 % as compared with only one in the case of the univariate analysis, whereby the 
results for the negative control are comparable. Regardless of the applied statistical method, 
predictions with significant relative errors were obtained for samples HV4, PS4 and PS5. The 
source of error might come from the measurements themselves, as the linear dependency of the 
detected signal satisfies the requirements of SAM. If these three samples are not considered for 
the mean absolute percentage error calculations, than MCR-ALS delivers predictions with an 
error of 6.2 %, whereas the univariate approach has an error of 12.5 %. Furthermore, the 
univariate statistical approach cannot be applied for the quantification of molecules presenting 
Raman bands convoluted with the Raman signal of the molecules present in the complex matrix. 
Consequently, MCR-ALS is the preferred approach for the determination of the antibiotic 
concentration in clinical samples.  
The total time needed for the determination of the “unknown” concentration for one 
sample was around 1 h. This time can be significantly reduced by (1) reducing the number of 
acquired spectra per SAS, (2) reducing the acquisition time and (3) optimizing the chip design. 
Currently, 600 SERS with 1 s integration time/spectrum were recorded for each SAS. In future 
measurements, this number can be reduced to at least half. The acquisition time can de reduced 
without compromising the signal-to-noise ratio by increasing the laser power. Because of the 
dynamic flow, local heating resulting in sample degradation is avoided. By changing these two 
parameters, a total run-time of 15 min/sample can be achieved. A new chip design with a single 
droplet generator with one inlet for the nanoparticles and five inlets for the unknown sample and 
the four SAS, longer meander channel as compared with the actual design, would reduce 
significantly the required time for measurement preparation. Furthermore, during the thesis it 
was also proved that the LoC-SERS setup can be easily combined with a portable Raman setup 
[IH3], without compromising the quality of the results (Figure 6).  
In conclusion, LoC-SERS-SAM has a high potential to find its place in clinical 
laboratories because of its low cost, time efficiency and good sensitivity. However, before this, 
further studies have to be carried out for different other molecules and for clinical samples.     
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1.4.5 Environmental Samples – ciprofloxacin determination 
 
 Monitoring the successful removal of antibiotics in waste and surface water is of high 
interest to overcome the occurrence of antibacterial resistance in the ecosystem. MICs for 
ciprofloxacin range between 0.024 µM for E. Coli to 12 µM for S. aureus. Surface water 
samples were collected from the shore of the local river (Saale). Prior to the measurements, the 
samples were filtered with the same filter used for the clinical samples. As a result, a clear 
solution was obtained. The water samples were spiked with ciprofloxacin and the measurements 
were performed at pH 11 with the LoC-SERS platform. In Figure 3 [IH5] the mean SERS 
spectra of selected samples is depicted. The SERS spectrum of the blank sample shows broad 
bands in the 1000-1700 cm
-1
 spectral region. They have been associated with the presence of 
amorphous carbon as a result of the decomposition of organic materials. Although the 
background signal is significant in the spectral region where ciprofloxacin characteristic Raman 
bands are located (1389 cm
-1
 and 1616 cm
-1
), at the lowest measured concentration, 0.74 µM, the 
signature of the target molecule is clearly distinguishable. For ciprofloxacin concentrations 
above 10µM the poisoning effect, previously discussed, appears. For data evaluation, the 
multivariate statistical analysis approach was successfully applied. Two independent data sets 
were recorded on two consecutive days with two different chips. The data of the first day was 
used to train the PLS model, whereas the second set was employed to assess the reproducibility 
of the measurements by treating it as “unknown” sample. The PLS training model was evaluated 
via a ten-fold cross validation. The RMSEP for cross validation was 0.375 µM, while that for the 
prediction on all data was 0.374 µM. The RMSEP value of prediction for the second, 
independent dataset, was 0.355 µM. The RMSEP value is the lowest concentration detectable 
and it can be used to estimate the LOD of the method. Furthermore, in the 0.74-10 µM 
concentration range great linearity is shown in Figure 4 (B) [IH5].  
 In conclusion, the LoC-SERS technique is suitable for detecting ciprofloxacin in 
environmental samples in the concentration range that corresponds to its MIC values. A “yes-
no” answer can be obtained, namely, if a SERS signal is detected, one might conclude that the 
ciprofloxacin concentration in the sample is above the MIC value. 
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1.5. Final Remarks 
  
 
 Immunoassays are commercially available only for MTX detection in clinical samples, 
while chromatography successfully quantifies MTX, levofloxacin, and ciprofloxacin, but the 
method is sophisticated and it is associated with high initial cost investment. Furthermore, no 
reliable detection of NTX was carried out up to date.  
Compared with the reference analytical methods, SERS is in its childhood when it 
comes to its real life application. One of the most often encountered challenges are related with 
the SERS active substrate. For analytical applications, the plasmonic structures used to enhance 
the inherently weak Raman scattering have to provide homogenous SERS signal and at the same 
time, they have to be easy-to-prepare and cost effective. Furthermore, it is highly desired that the 
target molecules have a high chemical affinity for the employed SERS substrate. Only under 
these conditions, its successful detection in complex matrices can be carried out. Thus, SERS is 
not a universal detector. Last, but not least, most of the reported measurement procedures offer 
no or very low automation, and hence, the measurement conditions are hard to control. Beside 
all this, the detection of specific molecules in complex matrices will bring additional challenges. 
Questions, such as: which is the best sample clean-up procedure, how to perform quantification 
of the molecules in chemically very divers samples or which is the optimal statistical data 
analysis approach, have to be answered. The aim of the current thesis was to address all the 
above mentioned challenges and to assess the potential of the LoC-SERS technique to be 
considered as an alternative analytical tool for the detection and quantification of drugs in 
complex matrices. 
For all the studies presented in the frame of the thesis, silver metallic nanoparticles in 
colloidal solution have been employed. Beside the MTX study, all experiments were carried out 
with nanoparticles synthesized at room temperature by the fast reduction of silver nitrate by 
hydroxylamine hydrochloride in the presence of sodium hydroxide. The prepared batches 
presented similar extinction spectra and they offered stable signal enhancement up to almost one 
year. Commonly encountered drawbacks of traditional cuvette based SERS measurements, such 
as aggregation time dependent signals and the precipitation of nanoparticles, were easily 
overcome by combining the measurement technique with a droplet based microfluidic platform. 
Simultaneously, also automation is achieved. Because of the reproducible measurement 
conditions, the relative standard deviation of the SERS signal, when no internal standard was 
applied, was generally below ~12 %.  
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As above mentioned, SERS is not an universal detector. Molecules have to efficiently 
adsorbed to the surface of the metallic nanoparticles. Additionally, because of the employed 
LoC-SERS platform, where aqueous droplets are formed in the continuous phase of mineral oil, 
a high water solubility of the molecules is a pre-requisite. This is the case for MTX, levofloxacin 
and ciprofloxacin. Nevertheless, because of the quinolone backbone, NTX is also partially 
soluble in the mineral oil. As a consequence, the molecules diffuse from the aqueous droplet 
toward the oil phase and the recorded SERS signal is significantly reduced. However, during the 
thesis it was shown, that the molecule has a strong chemical affinity for the employed 
nanoparticles and this inhibits their diffusion toward the mineral oil.    
Concerning the challenges brought by the presence of the molecules of the complex 
matrices for the SERS detection of the three antibiotics the following solutions were proposed: 
(1) filtration followed by dilution with water as sample clean-up procedure, (2) standard addition 
method for quantification and (3) multivariate statistic for data processing.  
 By applying the analytical procedure above described, the achieved results presented in 
the frame of the thesis demonstrate that all three antibiotics can be successfully detected in their 
complex matrices. Namely, due to the low metabolism rate of levofloxacin, LoC-SERS can be 
applied for monitoring its clearance rate short (up to 4-6 h) after the administration of a single 
oral dose of 500 mg. Furthermore, thanks to the high chemical affinity of NTX toward the silver 
surface, its successful quantification was carried out at MIC values when spiked in urine. The 
same was achieved for ciprofloxacin in surface water samples. 
 In conclusion, LoC-SERS offers manifold advantages such as: straightforward sample 
clean-up, specificity and sensitivity, quantification power, reproducibility and automation, small 
foot-print and on-site application. Future investigations should be directed toward clinical 
samples originating from patients under antibiotic treatment, the integration of nanoparticle 
synthesis in the same chip as the detection is carried out, extending the method for other drugs of 
interest and the investigation of other body fluids, such as blood. 
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